Systems and methods for controlling prosthesis based on amplified neural signals
By using bipolar electrode pairs and implantation equipment processing circuits between nerves and free tissue grafts, the problem of neural signal amplification is solved, and efficient signal transmission and feedback are achieved, improving the accuracy and stability of prosthesis control sex.
Patent Information
- Application Number
- CN202380036811.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-02-28
- Filing Date
- 2023-02-27
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to effectively process and transmit amplified signals from nerves to control the prosthesis, and it is difficult to efficiently transmit the perceptual feedback signal from the prosthesis back to the nerves, affecting the control accuracy and stability of the system.
The processing circuit of the implanted device receives electrical signals from free tissue grafts, contacts nerves through bipolar electrode pairs, and uses wireless communication to transmit the processed signal data to the prosthesis controller to realize signal amplification and processing, supporting Transmission of perceived feedback.
The signal-to-noise ratio of neural signals is improved, efficient control and feedback transmission of the prosthesis is achieved, and the control accuracy and stability of the system are enhanced.
Smart Images

Figure HDA0005104690220000011 
Figure HDA0005104690220000021 
Figure HDA0005104690220000031
Abstract
Description
[0001] CROSS-REFERENCE TO RELATED APPLICATIONS
[0002] This application claims the benefit of U.S. Provisional Application No. 63 / 314,531, filed on February 28, 2022. The entire disclosure of the above application is incorporated herein by reference. Technical Field
[0003] The present disclosure relates to systems and methods for controlling a prosthesis based on amplified neural signals, and more particularly, to systems and methods for controlling a prosthesis based on amplified signals from individual nerve bundles with an implantable regenerative peripheral nerve interface device, and to systems and methods for processing amplified signals to control a prosthesis. Background Art
[0004] This section provides background information related to the present disclosure which is not necessarily prior art.
[0005] There is a need to receive and record signals from nerves (e.g., human nerves) for subsequent processing and, for example, for controlling a prosthesis. A free tissue graft can be attached to a portion of a nerve (e.g., a nerve bundle), and the electrical signals from the nerve can be amplified by the free tissue graft. However, there is a need for systems and methods to effectively and efficiently process the amplified signals from the nerve and effectively and efficiently control the prosthesis based on the processed signals. In addition, there is a need for systems and methods to effectively and efficiently transmit sensory feedback signals from the prosthesis through the free tissue graft to the nerve. Summary of the invention
[0006] This section provides a general summary of the disclosure, and is not a comprehensive disclosure of the full scope of the disclosure or all of its various features.
[0007] The present disclosure provides methods and systems for receiving electrical signals from free tissue grafts using a processing circuit of an implanted device, the free tissue grafts being attached to nerves via bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the bipolar electrode pairs being in electrical communication with the free tissue grafts. The free tissue grafts are surgically attached to a subject such that the free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the free tissue grafts are autologous grafts of devascularized and denervated tissue harvested from the subject prior to surgical attachment to the subject. The electrical signals from the free tissue grafts have a voltage amplitude greater than or equal to about 150 microvolts. The processing circuit processes the electrical signals and wirelessly transmits the electrical signals to a prosthesis controller that controls the prosthetic device.
[0008] The present disclosure includes a system, the system comprising: an implant device having a processing circuit, the processing circuit being configured to receive electrical signals from a plurality of free tissue grafts, the plurality of free tissue grafts being surgically attached to a nerve of a subject; wherein the electrical signals are received by a plurality of bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the plurality of bipolar electrode pairs being implanted inside the plurality of free tissue grafts and in electrical communication with the plurality of free tissue grafts; the plurality of free tissue grafts being surgically attached to the subject such that the plurality of free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the plurality of free tissue grafts being autologous grafts of devascularized and denervated tissue harvested from the subject prior to being surgically attached to the subject; the processing circuit being further configured to process the received electrical signals, generate processed signal data, and wirelessly transmit the processed signal data to a prosthesis controller. After the plurality of free tissue grafts are surgically attached to the nerve, the nerve reinnervates the plurality of free tissue grafts. The electrical signals from the plurality of free tissue grafts have a voltage amplitude greater than or equal to about 150 microvolts. The prosthesis controller is configured to control the prosthetic device based on the processed signal data wirelessly transmitted from the processing circuitry of the implanted device.
[0009] In other features, the processing circuit is configured to apply a bandpass filter to the received electrical signal and to sample the filtered electrical signal.
[0010] In other features, the bandpass filter is a 100 Hertz (Hz) to 500 Hz bandpass filter, and the processing circuit is configured to sample the filtered electrical signal at a sampling rate of 1 kilohertz (kHz).
[0011] In other features, the processing circuit is further configured to generate processed signal data by calculating an average absolute value of the sampled electrical signal, and wirelessly transmit the average absolute value of the sampled electrical signal as the processed signal data to the prosthesis controller.
[0012] In other features, the implant device includes a protection circuit for protecting the implant device from surge voltages during an electrostatic discharge event while the implant device is implanted in a patient.
[0013] In other features, the protection circuit includes at least one resistor and at least one diode.
[0014] In other features, the multiple bipolar electrode pairs include a first group of bipolar electrode pairs and a second group of bipolar electrode pairs; wherein the first group of bipolar electrode pairs and the second group of bipolar electrode pairs are respectively connected to the implant device using a first multi-contact connector and a second multi-contact connector, each of which has a pair of contacts associated with a bipolar electrode pair; and wherein the implant device includes a header having a first port and a second port, and the first port and the second port are configured to receive the first multi-contact connector and the second multi-contact connector, respectively.
[0015] In other features, the first port and the second port each include a Bal Seal connector configured to seal the implant device 20 once the first multi-contact connector and the second multi-contact connector are inserted into the first port and the second port.
[0016] In other features, the prosthetic device includes at least one pressure sensor, the prosthetic controller is configured to: receive at least one pressure signal from the at least one pressure sensor, and transmit the pressure signal to the implant device; and the processing circuit of the implant device is also configured to: receive the pressure signal, and generate at least one stimulation signal and transmit the at least one stimulation signal to at least one of the plurality of bipolar electrode pairs to stimulate the subject's nerve through at least one of the plurality of free tissue grafts attached to the subject's nerve.
[0017] In other features, the processing circuitry of the implant device is configured to alternate the receipt of the electrical signal with the generation and transmission of the at least one stimulation signal during consecutive time periods.
[0018] In other features, the processing circuit is configured to generate commands to control the prosthetic device based on the received electrical signals and to generate estimated commands to control the prosthetic device during a time period when the at least one stimulation signal is generated and transmitted to the at least one bipolar electrode pair in the plurality of bipolar electrode pairs.
[0019] In other features, the processing circuit is configured to estimate artifacts within the electrical signal generated by the at least one stimulation signal and subtract the artifacts from the electrical signal.
[0020] The present disclosure also includes a method, the method comprising: receiving electrical signals from a plurality of free tissue grafts surgically attached to a nerve of a subject using an implant device having a processing circuit and a communication circuit; wherein the electrical signals are received by a plurality of bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the plurality of bipolar electrode pairs being implanted inside the plurality of free tissue grafts and in electrical communication with the plurality of free tissue grafts; the plurality of free tissue grafts being surgically attached to the subject such that the plurality of free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the plurality of free tissue grafts being autologous grafts of devascularized and denervated tissue harvested from the subject prior to being surgically attached to the subject. The method further comprises: processing the received electrical signals using the processing circuit. The method further comprises: generating processed signal data using the processing circuit. The method further comprises: wirelessly transmitting the processed signal data to a prosthesis controller using the communication circuit. After the plurality of free tissue grafts are surgically attached to the nerve, a portion of the nerve reinnervates the plurality of free tissue grafts. The electrical signals from the plurality of free tissue grafts have a voltage amplitude greater than or equal to about 150 microvolts. The prosthesis controller is configured to control the prosthetic device based on the processed signal data wirelessly transmitted from the processing circuitry of the implanted device.
[0021] In other features, the method further comprises applying, with the processing circuit, a bandpass filter to the received electrical signal and sampling, with the processing circuit, the filtered electrical signal.
[0022] In other features, the bandpass filter is a 100 Hz to 500 Hz bandpass filter and the sampling is performed at a sampling rate of 1 kHz.
[0023] In other features, the method further includes generating processed signal data by calculating, using the processing circuit, an average absolute value of the sampled electrical signal, and wirelessly transmitting, using the communication circuit, the average absolute value of the sampled electrical signal as the processed signal data to the prosthesis controller.
[0024] In other features, the implant device includes a protection circuit for protecting the implant device from surge voltages during an electrostatic discharge event while the implant device is implanted in a patient.
[0025] In other features, the protection circuit includes at least one resistor and at least one diode.
[0026] In other features, the multiple bipolar electrode pairs include a first group of bipolar electrode pairs and a second group of bipolar electrode pairs; wherein the first group of bipolar electrode pairs and the second group of bipolar electrode pairs are respectively connected to the implant device using a first multi-contact connector and a second multi-contact connector, each of which has a pair of contacts associated with a bipolar electrode pair; and wherein the implant device includes a head having a first port and a second port, and the first port and the second port are configured to receive the first multi-contact connector and the second multi-contact connector, respectively.
[0027] In other features, the first port and the second port each include a Bal Seal connector configured to seal the implant device 20 once the first multi-contact connector and the second multi-contact connector are inserted into the first port and the second port.
[0028] In other features, the prosthetic device includes at least one pressure sensor, and the method further includes: receiving, with a prosthetic controller, at least one pressure signal from the at least one pressure sensor; transmitting, with the prosthetic controller, the pressure signal to an implanted device; receiving, with a processing circuit of the implanted device, the pressure signal; and generating, with the processing circuit of the implanted device, at least one stimulation signal and transmitting the at least one stimulation signal to at least one of the plurality of bipolar electrode pairs to stimulate a nerve of the subject through at least one of the plurality of free tissue grafts attached to the nerve of the subject.
[0029] In other features, the processing circuitry of the implant device is configured to alternate the receipt of the electrical signal with the generation and transmission of the at least one stimulation signal during consecutive time periods.
[0030] In other features, the method further includes: generating, using a processing circuit of the implanted device, a command to control the prosthetic device based on the received electrical signal; and generating, using the processing circuit of the implanted device, an estimated command to control the prosthetic device during a time period in which the at least one stimulation signal is generated and transmitted to at least one of the plurality of bipolar electrode pairs.
[0031] In other features, the processing circuit is configured to estimate artifacts within the electrical signal generated by the at least one stimulation signal and subtract the artifacts from the electrical signal.
[0032] The present disclosure also includes a system, the system comprising: a computing device having a processing circuit, the processing circuit being configured to receive electrical signals from a plurality of free tissue grafts, the plurality of free tissue grafts being surgically attached to a nerve of a subject; wherein the electrical signals are received via a plurality of bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the plurality of bipolar electrode pairs being implanted within the plurality of free tissue grafts and in electrical communication with the plurality of free tissue grafts; the plurality of free tissue grafts being surgically attached to the subject such that the plurality of free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the plurality of free tissue grafts being autologous grafts of devascularized and denervated tissue harvested from the subject prior to being surgically attached to the subject; the processing circuit being further configured to process the received electrical signals, generate processed signal data, and transmit the processed signal data to a prosthesis controller. After the plurality of free tissue grafts are surgically attached to the nerves, portions of the nerves reinnervate the plurality of free tissue grafts. The electrical signals from the plurality of free tissue grafts have a voltage amplitude greater than or equal to about 150 microvolts. The prosthesis controller is configured to control the prosthetic device based on processed signal data transmitted from processing circuitry of the computing device. The plurality of bipolar electrode pairs are connected to electrical leads extending to the exterior of the subject and to a computing device located outside the subject that communicates with the prosthesis controller.
[0033] In other features, the processing circuit is configured to apply a bandpass filter to the received electrical signal and to sample the filtered electrical signal.
[0034] In other features, the bandpass filter is a 100 Hz to 500 Hz bandpass filter, and the processing circuit is configured to sample the filtered electrical signal at a sampling rate of 1 kHz.
[0035] In other features, the processing circuit is further configured to generate processed signal data by calculating an average absolute value of the sampled electrical signal, and wirelessly transmit the average absolute value of the sampled electrical signal as the processed signal data to the prosthesis controller.
[0036] Further areas of applicability will become apparent from the description provided herein.The description and specific examples in this summary are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] The drawings described herein are for illustrative purposes only of selected embodiments and not all possible implementations, and are not intended to limit the scope of the present disclosure.
[0038] Figure 1A regenerative peripheral nerve interface according to certain aspects of the present disclosure is shown.
[0039] Figure 2 Shown are three free muscle grafts after being harvested from a subject, and photographs showing a surgical procedure for surgically attaching the free muscle grafts to nerve bundles of the subject, in accordance with certain aspects of the present disclosure.
[0040] Figure 3 Another regenerative peripheral nerve interface and prosthetic device according to certain aspects of the present disclosure is shown.
[0041] Figure 4 Another regenerative peripheral nerve interface according to certain aspects of the present disclosure is shown.
[0042] Figure 5 is a block diagram of an implant device according to certain aspects of the present disclosure.
[0043] Figure 6 is a photograph of a hardware device chip according to certain aspects of the present disclosure.
[0044] Figure 7 is a block diagram of a processing circuit with memory and communication circuitry according to certain aspects of the present disclosure.
[0045] Figure 8 is a flow chart depicting an example control algorithm for recording amplified neural signal data according to certain aspects of the present disclosure.
[0046] Fig. 9 is a flow chart depicting an example control algorithm for controlling a prosthesis according to certain aspects of the present disclosure.
[0047] Fig.10 is a flow chart depicting an example control algorithm for decoding signals used to control a prosthesis in accordance with certain aspects of the present disclosure.
[0048] Fig.11 is a graph showing neural signal data corresponding to the onset of flexion movement.
[0049] Fig.12 is a flow chart depicting an example control algorithm for monitoring a nerve for pathological pain signals according to certain aspects of the present disclosure.
[0050] Fig.13 is a flow chart depicting an example control algorithm for monitoring pathological bladder contraction signals according to certain aspects of the present disclosure.
[0051] Fig.14 is a flow chart depicting an example control algorithm for stimulating a nerve based on a sensed pressure signal from a prosthetic device in accordance with certain aspects of the present disclosure.
[0052] Fig.15 is a graph showing neural signal data corresponding to the onset of finger flexion movement.
[0053] Fig.16 is a set of graphs showing neural signal data from an implanted regenerative peripheral nerve interface.
[0054] Fig.17 is a set of graphs showing data from an implanted regenerative peripheral nerve interface and from nerve signals controlling muscles.
[0055] Fig.18 is a graph showing neural signal data from an implanted regenerative peripheral nerve interface.
[0056] Fig.19 is a graph of predicted finger flexion percentage and actual finger flexion percentage versus time.
[0057] Fig. 20 A system for controlling a prosthesis based on amplified neural signals according to the present disclosure is shown.
[0058] Fig.21 Further shown is a system for controlling a prosthesis based on amplified neural signals according to the present disclosure.
[0059] Fig. 22 Electrical leads of a system for controlling a prosthesis based on amplified neural signals according to the present disclosure are shown.
[0060] Fig.23 Further shown are electrical leads of a system for controlling a prosthesis based on amplified neural signals according to the present disclosure.
[0061] Fig.24A An implant device including a head for receiving an eight-contact connector according to the present disclosure is shown.
[0062] Fig. 24B Another embodiment of an electrical lead for a system for controlling a prosthesis based on amplified neural signals according to the present disclosure is shown.
[0063] Fig.25 A protection circuit for an implant device according to the present disclosure is shown.
[0064] Fig.26 A functional block diagram for processing an amplified neural signal according to the present disclosure is shown.
[0065] Fig. 27 A prosthetic controller and a prosthetic hand according to the present disclosure are shown.
[0066] Fig.28 An external programmer charger and an inductive charging pad according to the present disclosure are shown.
[0067] Fig.29 An external programmer device in communication with an implant device and a prosthesis controller in accordance with the present disclosure is shown.
[0068] Fig.30 Another embodiment of a system for controlling a prosthesis based on amplified neural signals according to the present disclosure is shown.
[0069] Fig.31 An algorithm for generating prosthetic movement commands and performing stimulation in alternating time periods is shown.
[0070] Fig.32 Another algorithm for generating prosthetic motion commands and performing stimulation in alternating time periods while generating estimates of the prosthetic motion commands during time periods when stimulation is performed is shown.
[0071] Fig.33 Algorithms are shown for generating prosthesis motion commands and performing stimulation, while performing artifact estimation and subtraction to remove artifacts caused by the stimulation from the sensed signals.
[0072] Corresponding reference numerals indicate corresponding parts throughout the several views of the drawings.
[0073] It should be noted that for the purpose of describing certain embodiments, the drawings set forth herein are intended to illustrate the general characteristics of the methods, devices, materials, etc. of the present disclosure. These drawings may not accurately reflect the characteristics of any given embodiment and are not necessarily intended to fully define or limit the specific embodiments within the scope of the present disclosure. DETAILED DESCRIPTION
[0074] Example embodiments will now be described more fully with reference to the accompanying drawings.A non-limiting discussion of terms and phrases intended to aid in understanding the disclosure is provided at the end of this Detailed Description.
[0075] In various aspects, the present disclosure provides methods for amplifying a signal from a portion of a nerve (e.g., a separate nerve bundle) to a level higher than that generated by any conventional method or technique, and receiving the signal. Specifically, as described in more detail below, the present disclosure provides methods for amplifying a signal from a portion of a nerve (e.g., a separate nerve bundle) to a peak-to-peak value greater than or equal to about 150 microvolts peak-to-peak (μV pp), in some instances, greater than or equal to about 250 μV pp or 500 μV pp, and, for example, up to about 1000 μV pp or greater. As mentioned above, signals detected by previous neural interface systems are typically less than 100 μV pp when recorded from within a nerve and typically less than 10 μV pp when recorded from a cuff around a nerve. In certain aspects, the present disclosure provides an implantable neural interface device, also interchangeably referred to as a regenerative peripheral nerve interface (RPNI) device, that facilitates amplifying signals from individual nerve bundles to greater than or equal to about 150 μV pp, and in some instances, to greater than or equal to about 250 μV pp or 500 μV pp, and, for example, up to about 1000 μV pp or greater.
[0076] refer to Figure 1, a neural interface system 4 of an object or patient is shown. The object may be an animal with a complex nervous system, such as a mammal (such as a human, a primate, or a companion animal). A portion of the object's nerve 6 (e.g., a nerve ending) may be damaged or severed, for example, the nerve ending is completely or partially damaged due to injury, disease, or surgery. In some aspects, the method may include surgically dividing, severing, cutting, and / or transecting a portion of the nerve 6 into one or more separate branches or bundles 8. It should be noted that in some variations, the method may include isolating a portion of interest of the nerve 6 to produce the one or more separate branches or bundles 8. The one or more separate branches or bundles 8 are each placed in a free tissue graft 10. In some aspects, the free tissue graft 10 may be an autologous graft of muscle tissue or dermal tissue previously obtained from the object. In some preferred aspects, the free tissue graft 10 is muscle tissue. The free tissue graft 10 is obtained or removed so that it has a standard predetermined volume or size depending on the size of the branch or bundle 8. When the free tissue graft 10 is harvested, the tissue graft is devascularized and the native blood vessels are no longer functional. As will be described in more detail below, the predetermined volume of the free tissue graft 10 can be selected to be small enough to allow for proper revascularization through collateral blood flow, thereby allowing the free tissue graft 10 to thrive, while providing an area or volume of sufficient size for the branches or bundles 8 of the nerve 6 terminals to grow.
[0077] For example, over a period of several months, the nerve bundles 8 can reinnervate the free tissue graft 10 and grow nerve fibers 12 to find new neural targets. Once the free tissue graft 10 has been reinnervated, the action potentials from the neurons traveling along the nerve then generate muscle-level signal amplitudes, rather than nerve-level amplitudes. In this way, the free tissue graft 10 (e.g., a free muscle graft) acts as an amplifier of the signals generated by the branches or bundles 8 of the nerve 6 terminals, wherein the signals from a single nerve bundle 8 have a voltage amplitude greater than or equal to about 150 μV pp, in some instances, greater than or equal to about 250 μV pp or 500 μV pp, and, for example, up to about 1000 μV pp or more.
[0078] Although the neural interface system 4 can be used with any damaged, severed, or injured portion of a nerve within a subject (e.g., a nerve ending), the neural interface system is particularly suitable for use with peripheral nerves. Thus, the neural interface system 4 can be used with damaged or injured peripheral nerves, such as peripheral nerves involved in amputation. However, the methods described herein can also be used with a variety of different nerves. Therefore, in some aspects, although the methods of the present disclosure are particularly useful for peripheral nerves, the discussion of peripheral nerves and peripheral nerve interface devices is merely exemplary and not limiting.
[0079] like Figure 1 As shown, the free tissue graft 10 can be configured with an electrical conductor, such as an electrode 14, that is in electrical communication with the free tissue graft 10. As described in more detail below, the electrode 14 is in turn in electrical communication with a lead 18a, which is in electrical communication with an implant device 20, which includes a processing circuit 22 and an amplifier 24. In this case, the signal from the nerve bundle 8 is received by the electrode 14 and transmitted to the processing circuit 22 of the implant device 20 by the lead 18a, such as through the amplifier 24. Alternatively, the electrode 14 can be omitted, and the electrical conductor in electrical communication with the free tissue graft 10 can be a lead 18b placed directly in or on the free tissue graft 10. In this case, the signal from the nerve bundle 8 is received by the lead 18b itself through direct or indirect electrical communication with the free tissue graft 10, and transmitted to the processing circuit 22 of the implant device 20 by the lead 18b, such as through the amplifier 24. As another alternative, the electrical conductor in electrical communication with the free tissue graft 10 may be a wire grid 17 having a plurality of electrode sites and a plurality of conductive pathways placed in or on the free tissue graft 10. The wire grid 17 in turn is in electrical communication with a plurality of wires 18c, which are in electrical communication with the implant device 20. In this case, the signal from the nerve bundle 8 is received by the wire grid 17 and transmitted through the wires 18c, for example, via an amplifier 24 to a processing circuit 22 of the implant device 20. The amplifier 24 is a high impedance amplifier. In addition, although Figure 1 A single amplifier 24 is shown in the figure, but additional amplifiers may also be included in the implant device 20, including additional / separate amplifier circuits for one or more individual neural bundles 8 or groups of bundles 8. In addition, multiple implant devices 20 or implant devices with additional processing circuits 22 may also be used. As described herein, the neural interface system 4 can be an implantable neural interface device or RPNI device, which generally includes: a free tissue graft 10; associated wires 18a, 18b, 18c; an electrode 14 or a wire grid 17 with multiple electrodes (if any); and an implant device 20 with processing circuits 22.
[0080] As described in the present disclosure, implant device 20 may be, for example, a medical device implantable into a subject similar to an automatic cardiac defibrillator, but having processing capabilities to receive, process, record, and / or transmit neural signals received from free tissue graft 10. Because signals from individual neural bundles 8 are amplified by free tissue graft 10 (e.g., free muscle graft) to levels, for example, greater than or equal to about 150 μV pp or higher, the electronics contained within implant device 20 are smaller, less expensive, require less processing power, and / or consume less battery power than the electronics required to adequately and meaningfully receive, record, and process neural signals detected by previous systems, which, as described above, are typically less than 100 μV pp when received from within a nerve and typically less than 10 μV pp when received from a cuff around a nerve. In addition, because the signals from the individual nerve bundles 8 are amplified by the free tissue graft 10 to a level greater than or equal to about 150 μV pp or higher, for example, these signals are less susceptible to noise and interference, have a higher signal-to-noise ratio, and more accurately represent and correspond to the actual neural signals generated by the individual nerve bundles 8. For example, the signal-to-noise ratio of these signals can be 4 or higher. Notably, electrical signals at such levels can be generated by an implantable neural interface system 4, which in certain aspects substantially includes: a free tissue graft 10 and one or more electrical conductors (e.g., wires 18a, 18b, 18c, electrodes 14, and / or wire grid 17); and one or more portions of a nerve 6 that are regenerated and reinnervated in the free tissue graft.
[0081] In certain aspects, a method of amplifying a neural signal in a subject includes placing a portion of a nerve 6 (e.g., a nerve bundle 8) within a free tissue graft 10 and securing the portion of the nerve 6 (nerve bundle 8) therein. For example, the free tissue graft 10 may be attached to the nerve bundle 8 via suturing, gluing, tension, or other suitable attachment methods or mechanisms. Then, at least one electrical conductor (e.g., an electrode 14, a wire 18a, 18b, 18c, and / or a wire grid 17) may be introduced into the free tissue graft 10. It should be noted that the at least one electrical conductor may be introduced into the free tissue graft before securing a portion or branch of the nerve to the free tissue graft. The at least one electrical conductor provides electrical communication with the nerve 6. The electrical conductor may have a maximum thickness of less than or equal to about 5 millimeters (mm). Thus, one or more portions of the nerve 6 (nerve bundle 8) are regenerated within the free tissue graft that reinnervates the tissue. Such reinnervation may include the generation of outgrowing nerve fibers 12. In this manner, the nerve 6 is thus able to generate amplified electrical signals greater than or equal to about 150 microvolts as described above without any external electrical input. Notably, the ability to amplify electrical signals from the nerve and generate electrical signals from the nerve reflects the subject's autonomous, spontaneous generation of electrical signals at high voltage levels, which was not previously possible. Such autonomous, spontaneous electrical signals (e.g., electrical signals naturally generated from motor nerves) can be distinguished from stimulated neural signals generated by introducing external electrical input to the nerve for activation (e.g., stimulation by combined compound action potentials (CMAPs) caused by external neural activation).
[0082] In certain other aspects, the method may include: cutting a portion of a nerve in the object (e.g., cutting a nerve ending) to produce one or more branches or bundles. In certain aspects, cutting may include cutting the nerve ending into multiple parts, such as branches / bundles. Thus, for each corresponding part of the nerve, the placement of the nerve in the free tissue graft and the introduction of the electrical conductor into the free tissue graft assembly may be repeated. The method may also include: obtaining a free tissue graft from tissue of the object before processing the cut end. In certain aspects, the tissue is muscle tissue. In alternative aspects, the tissue may be dermal tissue. As will be discussed in more detail below, in certain aspects, the maximum dimension of the free tissue graft is less than or equal to about 10 centimeters (cm). In other aspects, the maximum dimension of the free tissue graft is less than or equal to about 5 cm.
[0083] In certain aspects, methods according to certain aspects of the present disclosure may also include: stimulating one or more portions (e.g., branches / fascicles) of a nerve using stimulation signals delivered via one or more electrical conductors in electrical communication with the free tissue graft. This provides the ability to deliver sensory feedback to the subject's brain via stimulation via the neural interface system 4.
[0084] refer to Figure 2 , three free tissue grafts 10 of free muscle tissue are shown after being harvested from a subject, but before being surgically attached to a nerve bundle of the subject. Figure 2 Also included is a photograph 28 showing a surgical procedure for surgically attaching a free tissue graft 10 to a subject's neural bundle. Further description of surgically attaching a free tissue graft 10 such as a muscle graft (also referred to as an autograft from a subject's free transplanted autologous muscle tissue block) to a neural bundle is provided in commonly assigned U.S. Publication 2013 / 0304174, published on November 14, 2013. The entire disclosure of U.S. Publication 2013 / 0304174 is incorporated herein by reference.
[0085] Since the free tissue graft 10 (e.g., a muscle graft) can be surgically harvested from non-essential donor muscle within a subject, the free tissue graft 10 undergoes a complete denervation process after being harvested, whereby the pre-existing innervation within the free tissue graft 10 is terminated. As described above, the harvesting process also causes devascularization of the native cells of the free tissue graft 10. Once the free tissue graft 10 is surgically attached to the nerve bundle 8, the free tissue graft 10 undergoes a reinnervation process, whereby the attached nerve bundle 8 reinnervates the free tissue graft 10 and grows nerve fibers 12, which grow within the free tissue graft 10 to seek new neural targets. After previously undergoing a denervation process, the signals from the newly attached nerve bundle 8 and the newly grown nerve fibers 12 do not have to compete with the residual nerve signals from the nerve bundles and nerve fibers that previously innervated the free tissue graft 10.
[0086] In addition, once the free tissue graft 10 is surgically reattached to the subject, it can obtain nutrients through the process of imbibition, rather than simply dying and being reabsorbed by the subject's body. Thus, if the free tissue graft 10 is within the optimal volume / size range, even without a native vascular blood supply, the free tissue graft 10 can absorb nutrients and blood through the surrounding tissue and fluid to support the process of reinnervation. Ultimately, as the free tissue graft 10 is reunited with the subject's body, a new blood supply network can be established. Following the process of denervation of the free tissue graft 10, this process of reinnervation of the free tissue graft 10 by the attached nerve bundles through the newly grown nerve fibers 12, combined with the process of imbibition and revascularization, creates an area of muscle or other tissue from which the implant device 20 can receive highly specific electrical signals, such as greater than or equal to about 150 μV pp or more, from individual nerve bundles 8, for example.
[0087] As mentioned above, in order to facilitate the reinnervation process and the imbibition process, the free tissue graft 10 is preferably within an optimal volume / size range. For example, the volume / size of the free tissue graft 10 can be selected to be small enough to allow it to be rapidly revascularized by collateral blood flow while providing an area or volume of sufficient size for the nerve to grow without forming an unorganized neuroma. In certain preferred aspects, the maximum dimension of the free tissue graft 10 can be less than or equal to about 10 cm. For example, in certain variations, the free tissue graft 10 can have a maximum dimension of less than or equal to about 10 cm in any direction. For example, in certain variations, the length of the free tissue graft 10 can be less than or equal to about 10 cm, or more preferably, less than or equal to about 5 cm. In addition, the width of the free tissue graft 10 can be less than or equal to about 10 cm, or more preferably, less than or equal to about 5 cm. The thickness of the free tissue graft 10 can optionally be less than or equal to about 2 cm to 3 cm. In addition, the optimal dimensions of the free tissue graft 10 may include a length of less than or equal to about 5 cm, and a diameter of greater than or equal to about 2 cm to less than or equal to about 3 cm. For example, the preferred optimal dimensions of the free tissue graft 10 may include a length of about 3.5 cm, and a diameter of about 2 cm. It should be noted that the free tissue graft 10 may have a variety of different sizes and / or geometries, and those sizes and / or geometries described herein are exemplary. In addition, for example, a discussion of the dimensions of a free transplanted piece of autologous muscle tissue from a subject is included in paragraphs
[0082] to
[0088] of U.S. Publication 2013 / 0304174, published on November 14, 2013, which is incorporated herein by reference in its entirety.
[0088] refer to Figure 3, shows an example embodiment 100 having a plurality of free tissue grafts 10 (e.g., free muscle grafts) and electrodes 14 connected to an implant device 20. The implant device, in addition to receiving signals from individual nerve bundles through the free tissue grafts 10 and electrodes 14, also controls a terminal device, which in this case is a prosthetic hand 110. Specifically, as shown Figure 3 As shown, each of the radial nerve 102 , the median nerve 104 , and the ulnar nerve 106 has been divided into a plurality of separate nerve bundles that have been attached to corresponding free tissue grafts 10 and are in electrical communication with the processing device 22 of the implant device 20 via electrical communication with the electrodes 14 .
[0089] As discussed in more detail below, the processing circuitry 22 of the implant device 20 monitors the signals from the various beams and controls, for example, flexion and extension of the prosthetic hand 110 based on an analysis of the received signals. For example, as discussed in more detail below, training data may be obtained through a calibration process in which a subject is asked to perform specific movements while neural signals are monitored and recorded by the processing circuitry 22 of the implant device 20 and transmitted to an external computing device such as a desktop or laptop computer. The training data set is then analyzed and used to estimate parameters that the processing circuitry 22 uses to drive the prosthetic hand 110, and these parameters are then downloaded from the external computing device to the processing circuitry 22 of the implant device 20. For example, as discussed in more detail below, the training data set may be obtained through a calibration process in which a subject is asked to perform specific movements while neural signals are monitored and recorded by the processing circuitry 22 of the implant device 20 and transmitted to an external computing device such as a desktop or laptop computer. The training data set is then analyzed and used to estimate parameters that the processing circuitry 22 uses to drive the prosthetic hand 110, and these parameters are then downloaded from the external computing device to the processing circuitry 22 of the implant device 20. Figure 3 As shown, the implant device 20 is in communication with actuators 112 which drive flexion and extension of the various fingers of the prosthetic hand 110 as described in more detail below.
[0090] refer to Figure 4 In addition to sensing or reading signals generated by nerve bundles 8 and amplified by free tissue grafts 10, the RPNI device of the present disclosure can also be used to stimulate individual nerve bundles 8 or individual nerve fibers. Figure 4 As shown, the free tissue graft 10 is configured with three electrodes 30a, 30b, 30c, which communicate with the processing circuit 22 of the implant device 20 through amplifiers 32, 32b, 32c and wires 34a, 34b, 34c. In this way, as discussed in more detail below, the processing circuit 22 can stimulate the individual nerve bundles 8, for example, using negative voltage stimulation signals or positive voltage inhibition stimulation signals. Generally speaking, negative voltage signals will cause nerves to fire, while positive voltages will inhibit nerve firing.
[0091] Existing clinical applications (e.g., vagus nerve stimulation) typically use a cuff to wrap around the entire nerve. In this way, a large portion of the nerve is usually stimulated. However, using Figure 4In the RPNI device shown, the processing circuit 22 can process the stimulation of a specific bundle by directing the signal to the electrodes 30a, 30b, 30c via the wires 34a, 34b, 34c. More specifically, the use of the free tissue graft 10 can allow a single bundle 8, which may be approximately 1 mm in diameter, to be expanded into a 1 cm by 3.5 cm structure for the purpose of stimulation. Stimulating the entire structure (i.e., the entire free tissue graft 10) can specifically process the corresponding single bundle 8.
[0092] Furthermore, by using multiple electrical contacts (e.g., multiple electrodes), current steering can be used to achieve stimulation of a more specific area (e.g., a small portion of bundle 8 or an individual fiber). For example, when stimulating with only a single negative contact, the negative voltage may spread and dissipate. Conversely, by using current steering, the negative voltage can be surrounded by the positive voltage to concentrate the negative voltage at a single location. Figure 4 , a negative voltage may be applied using electrode 30b, while a positive voltage may be applied using electrodes 30a and 30c, so as to provide more attention to the position where the negative voltage is applied from electrode 30b.
[0093] As discussed in more detail below, for example, neurostimulation can be used to sense the prosthesis to stimulate nerves in response to pressure sensed by the prosthesis's pressure sensor. Additionally, neurostimulation can be used to inhibit pathological pain signals. Additionally, neurostimulation can be used, for example, to inhibit pathological contractions of the bladder. Additionally, neurostimulation can be used for sphincter control, erectile dysfunction, and / or to control nerves associated with internal organs such as the liver, adrenal glands, stomach, pancreas, and kidneys. For example, such neurostimulation can be used on the renal artery to interfere with and treat abnormal nerve signals in the kidneys that might otherwise cause high blood pressure.
[0094] refer to Figure 5 , further details of the implant device 20 are shown. As described above, the implant device 20 can be (e.g. Figure 1 The leads 18a, 18b, 18c shown in FIG. 1A receive amplified neural signal input 52 from the free tissue graft 10. As discussed further above, the implant device 20 may be implanted via (eg, Figure 4 The wires 34a, 34b, 34c (shown) transmit the neural stimulation signal output 54 to stimulate the nerves using the electrodes 30a, 30b, 30c. As discussed further above, the implant device 20 can transmit the prosthesis control signal output 56 to control the movement of the prosthetic device. For example, the implant device 20 can transmit the prosthesis control signal output 56 via a data bus such as a controller area network (CAN) bus to control (e.g., Figure 3For example, the implant device 20 may transmit a prosthesis control signal output 56 to control the flexion and extension of the prosthetic hand 110 (as shown). Figure 3 ) of the respective actuators 112. In addition, as discussed further above, for example, the implant device 20 can receive prosthesis sensor input signals 58 generated by one or more pressure sensors that correspond to pressures sensed by pressure sensors of the prosthesis. As described above, the implant device 20 can generate a neural stimulation signal output 54 based on the pressure sensor signal inputs from the pressure sensors of the prosthesis received by the implant device.
[0095] like Figure 5 As shown, the implant device includes a processing circuit 22 and a communication circuit 50 and a memory 62, both of which are in communication with the processing circuit 22. The communication circuit 50 enables the implant device (and in particular the processing circuit 22 of the implant device 20) to communicate wirelessly with a computing device external to the implant device 20, which includes, for example, a computing device external to the subject, such as a desktop computer or a laptop computer. In this way, the processing circuit 22 can transmit data, such as amplified neural signal input data received via the amplified neural signal input 52. Such communication can be used during the calibration process to receive training data and calibration data from the implant device 20 at an external computing device for viewing and analysis, as well as to transmit estimated operating parameters and configuration data used by the implant device 20, for example, to drive a prosthesis or generate neural stimulation signal outputs. The communication circuit 50 may include an antenna and a receiver and transmitter, or a transceiver, for communicating via a wireless radio frequency (RF) 60. For example, the communication circuit 50 may communicate via a wireless protocol such as the CEN ISO / IEEE 11073 communication protocol for communication between medical devices and external information systems. or Other wireless protocols for communication.
[0096] Memory 62 may be used by processing circuitry 22 to store, for example, amplified neural signal input data received via amplified neural signal input 52 prior to communicating with an external computing device via communication circuitry 50. Memory 62 may also be used to store estimated operating parameters and configuration data received from an external computing device and used by the implanted device during operation. Memory 62 may also be used by processing circuitry 22 to store event or operating history data, or any other data associated with various inputs and outputs received or generated by processing circuitry 22.
[0097] refer to Figure 6, showing a hardware device chip 64, which may include or be used to implement (eg Figure 5 The hardware device chip 64 may also include or be used to implement (such as Figure 1 The amplifier 24 shown in FIG. Figure 4 The hardware device chip 64 may preferably include a high input impedance bio-amplifier configured to process the high output impedance bio-signals received from the free tissue graft 10. In addition, the hardware device chip 64 may preferably include functionality for suppressing large common mode signals, such as recording differentially from paired electrodes, referencing the received signals to a local reference near one or more RPNI devices, or using a stronger high pass filter in the first stage. The hardware device chip 64 may preferably include an amplifier for amplifying the received signals from the nerve bundle 8, for example, by 1000 times. Preferably, the hardware device chip 64 has very low noise, but this feature may not be so important considering the relatively high amplitude of the received amplified neural signal input from the nerve bundle 8. In addition, the hardware device chip 64 may preferably include a bandpass filter for filtering the received amplified neural signal input between 10000 Hz and 2000 Hz before further processing. Additionally, the hardware device chip 64 may preferably take the absolute value in the analog domain of the received amplified neural signal input.
[0098] refer to Figure 7, further details of the processing circuit 22 are shown, which is shown to be in communication with the communication circuit 50 and the memory 62 of the implant device 20. The processing circuit 22 includes a neural input signal conditioning circuit 70, which is used to receive and condition the amplified neural signal input 52 from the neural bundle received through the free tissue graft 10. The function and operation of the neural input signal conditioning circuit 70 are discussed in more detail below. The processing circuit 22 also includes a neural input signal decoding circuit 72, which is used to process and decode the signal data conditioned by the neural input signal conditioning circuit 70. The function and operation of the neural input signal decoding circuit 72 are discussed in more detail below. The processing circuit 22 also includes a neural stimulation signal output circuit 74, which is used to generate the neural stimulation signal output 54. The function and operation of the neural stimulation signal output circuit 74 are discussed in more detail below. The processing circuit 22 also includes a prosthesis control circuit 76, which is used to generate the prosthesis control signal output 56 for controlling the prosthesis. The functionality and operation of the prosthesis control circuit 76 is discussed in more detail below. The prosthesis control signal output 56 for controlling the prosthesis may be transmitted to the prosthesis via a data bus such as a CAN bus. The processing circuit 22 also includes a prosthesis sensor receiver circuit 78 for receiving a prosthesis sensor signal input 58 from a pressure sensor of the prosthesis. The functionality and operation of the prosthesis sensor receiver circuit 78 is discussed in more detail below.
[0099] refer to Figure 8 , a control algorithm 800 for receiving and recording amplified neural signal data from a free tissue graft 10 is shown. The control algorithm 800 may be executed by the processing circuit 22 of the implant device 20. More specifically, the control algorithm 800 may be executed at least in part by the processing circuit 22 (e.g., Figure 7 The control algorithm 800 begins at 802 .
[0100] At 804, the neural input signal conditioning circuit 70 of the processing circuit 22 receives one or more amplified neural signals from a conductor in electrical communication with one or more free muscle grafts. Figure 1 As described in detail, the electrical conductor may be an electrode 14, a wire grid 17, or a wire 18b in electrical communication with the free tissue graft 10. As further described above, the voltage amplitude of the electrical signal may be greater than or equal to about 150 μV pp, and in some instances, greater than or equal to about 250 μV pp or 500 μV pp, and for example, up to about 1000 μV pp or greater. In addition, in the use of (e.g. Figure 1In the embodiment of the amplifier 24 shown in FIG. 1 , the signal may be amplified before being received by the processing circuit 22. In this case, for example, the signal may be pre-conditioned by amplifying it 1000 times using the amplifier 24 before being received by the neural input signal conditioning circuit 70 of the processing circuit 22.
[0101] At 806, the neural input signal conditioning circuit 70 of the processing circuit 22 conditions the received signal from the free tissue graft 10 and extracts features from the received signal from the free tissue graft. Figure 1 In an embodiment of the amplifier 24 shown in FIG. 1 , the neural input signal conditioning circuit 70 can amplify the received signal, for example, by 1000 times. The neural input signal conditioning circuit 70 can then filter the received signal using a predetermined analog frequency range. For example, the predetermined analog frequency range can be between 10 Hz and 1000 Hz or between 10 Hz and 2000 Hz. After filtering, the neural input signal conditioning circuit 70 can digitize the filtered signal using a predetermined sampling rate. For example, the neural input signal conditioning circuit 70 can digitize the filtered signal using a sampling rate of 30,000 samples per second. The digitized signal can then be digitally filtered using a predetermined digital frequency range. For example, the predetermined digital frequency range can be 100 Hz to 500 Hz. After digital filtering, the signal can then be downsampled to 1000 samples per second. Since the voltage amplitude of the initially received signal is relatively large, the conditioning and feature extraction performed in step 806 will produce a robust and clear signal that is less susceptible to noise or interference than a system that does not utilize a free tissue graft 10 to amplify the signal from the nerve bundle.
[0102] At 808, the processing circuit 22 records the resulting signal data in the memory 62 and / or transmits the resulting signal data to an external computing device using the communication circuit 50. For example, the resulting signal data may be stored in the memory 62 of the implant device 20 and then transmitted to the external computing device via a batch communication process by the communication circuit 50. Alternatively, the memory 62 may be used as a buffer to receive and store the resulting signal data for further processing by the processing circuit 22 or transmission to the external computing device via the communication circuit 50. Alternatively, the resulting signal data may be streamed to the external computing device via the communication circuit 50 in real time.
[0103] After recording or transmitting the resulting signal data at 808, the processing circuit 22 loops back to 804 and continues to receive one or more amplified neural signals. Although the control algorithm 800 is shown as a series of steps for illustrative purposes, it should be understood that the various steps may continue to occur in parallel by the processing circuit 22 as the amplified neural signals are continuously received in real time.
[0104] refer to Fig. 9 , showing a method for controlling a device such as (e.g., Figure 3 The control algorithm 900 may be executed by the processing circuit 22 of the implant device 20. More specifically, the control algorithm 900 may be executed at least in part by the processing circuit 22 (e.g., Figure 7 The control algorithm 900 is executed by the neural input signal conditioning circuit 70, the neural input signal decoding circuit 72 and the prosthesis control circuit 76 as shown. The control algorithm 900 starts at 902.
[0105] At 904, the neural input signal conditioning circuit 70 of the processing circuit 22 receives one or more amplified neural signals from a conductor in electrical communication with one or more free muscle grafts. Figure 8 Step 804 in describes the function of step 904, which will not be repeated here.
[0106] At 906, neural input signal conditioning circuitry 70 of processing circuitry 22 conditions and extracts features from the received signal from free tissue graft 10. Figure 8 Step 806 in describes the function of step 906, which will not be repeated here.
[0107] At 908, the neural input signal decoding circuit 72 decodes the resulting signal data to determine whether the resulting signal data corresponds to flexion or extension of the prosthesis, for example. Fig. 9 The control algorithm 900 in FIG. 1 is described in terms of decoding the obtained signal data for a flexion motion or an extension motion, but it should be understood that other prosthetic control motions may be similarly decoded from the obtained signal data, where appropriate. The neural input signal decoding circuit 72 may use a one of two classifier (e.g., a naive Bayes classifier) or regression analysis to determine whether the obtained signal data over a predetermined time segment, such as 25 milliseconds (ms), indicates flexion or extension. The following references Fig.10 The illustrated control algorithm 1000 for decoding signals to control a prosthesis describes further details for decoding the resulting signal data.
[0108] At 910, the processing circuit 22 determines whether the obtained signal data within the predetermined time period segment corresponds to flexion or extension of the prosthesis. At 910, when the obtained signal data corresponds to extension, the processing circuit proceeds to 912, and the prosthesis control circuit 76 of the processing circuit 22 drives the prosthesis in the extension direction. At 910, when the obtained signal data corresponds to extension, the processing circuit proceeds to 914, and the prosthesis control circuit 76 of the processing circuit 22 drives the prosthesis in the flexion direction. For example, in the case of Figure 3 In the case of the prosthetic hand 110 shown, the processing circuit 22 may drive the actuator 112 of the prosthetic hand 110 in either a flexion direction or an extension direction, as appropriate. After actuating the prosthesis at steps 912 or 914, the processing circuit 22 loops back to 904.
[0109] refer to Fig.10 , a control algorithm 1000 for decoding a signal to control a prosthesis is shown. The control algorithm 1000 may be executed by the processing circuit 22 of the implant device 20. More specifically, the control algorithm 1000 may be at least partially executed by the neural input signal decoding circuit 72. Fig.10 The control algorithm 1000 shown functions in Fig. 9 The control algorithm 1000 begins at 1002 .
[0110] At 1004, the neural input signal decoding circuit 72 determines whether the current sample group within the predetermined time segment is complete. For example, the predetermined time segment may be 25 ms, and the sampling interval may be an interval of 1 ms. In this case, the neural input signal decoding circuit 72 may wait at step 1004 until a complete sample group of 25 samples at intervals of 1 ms is complete. When the sample group is not complete, the neural input signal decoding circuit 72 loops back to 1004. When the sample group is complete, the neural input signal decoding circuit 72 proceeds to 1006.
[0111] At 1006, the neural input signal decoding circuit 72 classifies each sample in the sample group using a binary classifier. For example, when the neural input signal decoding circuit 72 is decoding the resulting signal data for flexion or extension, the neural input signal decoding circuit 72 may classify each sample in the sample group as a flexion sample or an extension sample. For example, the neural input signal decoding circuit 72 may classify each sample in the sample group as a flexion sample or an extension sample using a binary naive Bayes classifier or regression analysis.
[0112] The alternative naive Bayes classifier can use training data previously collected from the subject during calibration procedures and routines. For example, the subject can be commanded to perform a flexion motion or an extension motion, and the resulting neural signal data can be recorded by the processing circuit 22 and transmitted to an external computing device for analysis. Based on the collected training data, the Gaussian distribution of each of the flexion motion and the extension motion can be estimated or calculated based on the received neural signal data. For example, the Gaussian distributions of the flexion motion and the extension motion will have different means and variances. The parameters and data of the alternative naive Bayes classifier can be estimated by an external computing device based on the collected training data, and then transmitted to the processing circuit 22 and stored in the memory 62 for use by the neural input signal decoding circuit 72 to decode the neural signal data.
[0113] During step 1006, the neural input signal decoding circuit 72 can compare each sample within the sample group with previously determined Gaussian distributions with different means and variances for flexion and extension movements, and calculate the probability that the particular sample is drawn from each of the two distributions. Each sample is then classified based on which of the two movements has a higher probability for the particular sample. For example, if a particular sample has a higher probability that it corresponds to a flexion movement, the sample is classified as a flexion sample. If a particular sample has a higher probability that it corresponds to an extension movement, the sample is classified as an extension sample. Once all samples within the sample group have been classified, the neural input signal decoding circuit 72 proceeds to 1008.
[0114] At 1008, the neural input signal decoding circuit 72 determines whether there are more flexion samples or more extension samples in a particular sample group, and classifies the entire sample group based on the determination result. For example, when there are more flexion samples in the sample group, the sample group is classified as a flexion sample group, and when there are more extension samples in the sample group, the sample group is classified as an extension sample group. In this way, the neural input signal decoding circuit 72 predicts whether a group of samples in a particular sample group indicates, for example, a flexion movement or an extension movement. It should be understood that other movements can be similarly included in the classification and prediction process. After classifying the sample group, the neural input signal decoding circuit 72 loops back to 1004.
[0115] In this way, reference Fig. 9 and Fig.10In both cases, the processing circuit 22 can, for example, determine or predict whether the neural signal data within a specific predetermined time period segment (e.g., 25ms) corresponds to or indicates a flexion movement or an extension movement. In addition, the prosthesis control circuit 76 can send control commands to the prosthesis every 25ms based on the classification of the current sample group or the most recent sample group. In this way, the processing circuit 22 can continuously monitor and decode the neural signal data and send corresponding commands to operate the prosthesis. Although predetermined time period segments are used to describe the above examples, it should be understood that shorter or longer predetermined time period segments can be used.
[0116] refer to Fig.11 , shows an example graph with neural signal data over a 5 second period corresponding to the onset of a flexion movement. Fig.15 , shows an example graph having neural signal data over a 400 millisecond time period corresponding to the onset of a finger flexion movement.
[0117] As mentioned above Fig. 9 and Fig.10 As described, the training data collected from the subject during the calibration routine can be used to generate, for example, a mapping of received neural signals to corresponding prosthetic movements or prosthetic actions. In the example of a transradial amputee, individual neural bundles may map well to individual hand muscles simulated with the prosthesis. In the example of a transhumeral amputee, the training data can be used to determine which neural bundles or groups of neural signal inputs are most correlated with which individual hand muscles simulated with the prosthesis.
[0118] In addition, neural signal data (e.g., average signal power, number of zero-crossing events, or counts of detected spikes) can be monitored, recorded, and analyzed for each signal from each neural bundle, and used, for example, to calculate the desired velocity for all five fingers of a prosthetic hand to be sent to the prosthetic hand in a single command at each time step (e.g., every 25 ms). There is no one-to-one correspondence between a specific muscle and the velocity of an individual finger. For example, to flex only the little finger, the subject may need to extend the index finger at the same time. Therefore, finger velocity can be regressed on muscle activity on all neural signal channels to determine a consistent overall mapping. Various algorithms can be used to estimate instantaneous velocity based on various signals, including, for example, linear filters, Kalman filters, and particle filters.
[0119] In addition, a linear discriminant, a naive Bayes classifier, or a support vector machine can be used to predict a single discrete state, such as grasping and pointing. In each case, a training data set is obtained through a calibration process by requiring the subject to perform various movements or actions and using the implant device 20 and the processing circuit 22 to monitor and record the resulting neural signal data. The training data set can then be used to estimate the operating parameters used by the processing circuit 22 and, for example, the prosthesis control circuit 76 to control the prosthetic hand. The estimated operating parameters can then be downloaded to the processing circuit 22 via the communication circuit 50 and stored in the memory 62 for use by the processing circuit 22, for example, to estimate finger velocity in real time to drive the prosthetic hand.
[0120] refer to Fig.12 , a control algorithm 1200 for monitoring pathological pain signals of a nerve is shown. The control algorithm 1200 may be executed by the processing circuit 22 of the implanted device. More specifically, the control algorithm 1200 may be executed at least in part by the neural input signal conditioning circuit 70, the neural input signal decoding circuit 72, and the neural stimulation signal output circuit 74. The control algorithm 1200 starts at 1202.
[0121] At 1204, the neural input signal conditioning circuit 70 of the processing circuit 22 receives one or more amplified neural signals from a conductor in electrical communication with one or more free muscle grafts. Figure 8 Step 804 in describes the function of step 1204, which will not be repeated here.
[0122] At 1206, the neural input signal conditioning circuit 70 of the processing circuit 22 conditions the received signal from the free tissue graft 10 and extracts features from the received signal from the free tissue graft. Figure 8 Step 806 in describes the function of step 1206, which will not be repeated here.
[0123] At 1208, the neural input signal decoding circuit 72 decodes the obtained signal data to determine whether the obtained signal data indicates a pathological pain signal, for example. The decoding performed at 1208 is similar to the above reference Fig. 9 Step 908 and Fig.10 The decoding described in steps 1004 to 1008 of the above reference describes decoding the obtained signal data to determine whether the obtained signal data indicates a flexion movement or an extension movement. Fig. 9 and Fig.10Similar to the decoding described, the decoding performed at 1208 can be based on a training data set collected during a calibration procedure with a subject, similarly using a binary classifier such as a naive Bayes classifier to determine whether the resulting signal data corresponds to a state where a pathological pain signal is being generated. After decoding the resulting signal at 1208, the processing circuit 22 proceeds to 1210.
[0124] At 1210, the processing circuit 22 determines whether a pathological pain signal has been detected based on the decoding of the obtained signal data. When a pathological pain signal is detected, the processing circuit 22 proceeds to 1212 and stimulates the appropriate nerve bundle with inhibitory stimulation. Specifically, the nerve stimulation signal output circuit 74 of the processing circuit 22 can stimulate the appropriate nerve bundle with a positive voltage to inhibit nerve activity and inhibit or reduce pathological pain signal activity in the nerve bundle. In this way, pain signals in the subject can be alleviated without permanently losing perception of a specific nerve or nerve bundle at the tissue. At 1212, after the nerve is stimulated using the inhibitory stimulation, or at 1210, after determining that no pathological pain signal is detected, the processing circuit 22 loops back to 1204.
[0125] refer to Fig.13 , a control algorithm 1300 for monitoring pathological bladder contraction signals is shown. The control algorithm 1300 may be executed by the processing circuit 22 of the implanted device. More specifically, the control algorithm 1300 may be executed at least in part by the neural input signal conditioning circuit 70, the neural input signal decoding circuit 72, and the neural stimulation signal output circuit 74. The control algorithm 1300 starts at 1302.
[0126] At 1304, the neural input signal conditioning circuit 70 of the processing circuit 22 receives one or more amplified neural signals from a conductor in electrical communication with one or more free muscle grafts. Figure 8 Step 804 in describes the function of step 1304, which will not be repeated here.
[0127] At 1306, the neural input signal conditioning circuit 70 of the processing circuit 22 conditions the received signal from the free tissue graft 10 and extracts features from the received signal from the free tissue graft. Figure 8 Step 806 in describes the function of step 1306, which will not be repeated here.
[0128] At 1308, the neural input signal decoding circuit 72 decodes the resulting signal data to determine whether the resulting signal data indicates, for example, a pathological bladder contraction signal. The decoding performed at 1308 is similar to that described above with reference to Fig. 9 Step 908 and Fig.10 The decoding described in steps 1004 to 1008 of the above reference describes decoding the obtained signal data to determine whether the obtained signal data indicates a flexion movement or an extension movement. Fig. 9 and Fig.10 Similar to the decoding described above, the decoding performed at 1308 can be based on a training data set collected during a calibration procedure with a subject, similarly using a binary classifier such as a naive Bayes classifier to determine whether the resulting signal data corresponds to a state that is generating a pathological bladder contraction signal. After decoding the resulting signal at 1308, the processing circuit 22 proceeds to 1310.
[0129] At 1310, the processing circuit 22 determines whether a pathological bladder contraction signal has been detected based on the decoding of the obtained signal data. When a pathological bladder contraction signal is detected, the processing circuit 22 proceeds to 1312 and stimulates the appropriate nerve bundle with inhibitory stimulation. Specifically, the nerve stimulation signal output circuit 74 of the processing circuit 22 can stimulate the appropriate nerve bundle with a positive voltage to inhibit nerve activity and inhibit or reduce pathological bladder contraction signal activity in the nerve bundle. At 1312, after stimulating the nerve with inhibitory stimulation, or at 1310, after determining that a pathological pain signal is not detected, the processing circuit 22 loops back to 1304.
[0130] Although reference Fig.13 The control algorithm 1300 described is described in the context of monitoring and inhibiting pathological bladder contraction signals, but the control algorithm can be similarly applicable to other applications. For example, the control algorithm 1300 can be appropriately applied to sphincter control or erectile dysfunction. Similarly, the control algorithm 1300 can be applicable to control nerves associated with internal organs such as the liver, adrenal glands, stomach, pancreas, and kidneys, for example. In each case, training data is collected from the subject and analyzed to generate appropriate monitoring parameters, which are then downloaded to the implant device 20. The implant device 20 then monitors the nerve signal activity to determine whether nerve stimulation is appropriate.
[0131] refer to Fig.14 , shows a control algorithm 1400 for stimulating nerves based on sensed pressure signals from a prosthetic device. For example, Figure 3A prosthetic device such as the prosthetic hand 110 shown may be equipped with a pressure sensor, for example, located in the fingertips of the prosthesis. The pressure sensor may sense the pressure and transmit the pressure signal back to the processing circuit 22 of the implanted device 20. The control algorithm 1400 may be executed by the processing circuit 22 of the implanted device. More specifically, the control algorithm 1400 may be executed at least in part by the prosthetic sensor receiver circuit 78 and the neural stimulation signal output circuit 74. The control algorithm 1400 begins at 1402.
[0132] At 1404, the prosthesis sensor receiver circuit 78 receives pressure signals from the pressure sensors of the prosthesis, which pressure signals correspond to the pressures sensed at the locations of these pressure sensors. At 1406, the neural stimulation signal output circuit 74 stimulates individual neural bundles based on the received sensed pressure signals. A calibration procedure with the subject can be used to generate training data to determine which individual neural bundles should be most appropriately mapped to which pressure sensors. In addition, the discharge rate or level of the stimulation can correspond to the level of pressure sensed by the pressure sensors. In this way, the implanted device can transmit tactile feedback signals from the prosthesis to the appropriate neural bundles.
[0133] The following specific examples are provided for the purpose of illustrating how to make and use the compositions, apparatus and methods of the present technology, and unless otherwise expressly stated, these specific examples are not intended to represent that a given embodiment of the present technology has been made or tested, or has not been made or tested.
[0134] Example
[0135] Example 1
[0136] RPNI studies in non-human primates
[0137] In the following example, RPNIs were surgically implanted in the forearms of two non-human primates (Monkey R and Monkey L). Specifically, Monkey R was implanted with three RPNIs and Monkey L was implanted with four RPNIs. The muscle grafts were attached to small branches of the median and radial nerves to provide independent finger flexion / extension signals and thumb flexion signals. The surgery followed a standard operating procedure checklist, and the animals were monitored daily in their cages for ten days post-surgery and then observed in the primate chair during daily experiments thereafter.
[0138] No major complications were found, and the animals regained normal use of the limb within a week after surgery. In the second surgery for two animals, significant revascularization of the muscle graft was observed. RPNI responded to electrical stimulation with large amplitude compound muscle action potentials (CMAP), indicating reinnervation of the muscle graft by the implanted nerve bundle.
[0139] In the third surgery for monkey L, four bipolar "IM-MES" intramuscular electrodes manufactured by Ardiem Medical were implanted in two mature RPNIs and in a healthy, intact muscle (extensor carpi radialis brevis (ECRB), a wrist extensor) for comparison. One electrode was placed in the muscle graft of the newly generated RPNI structure, which then matured within three months to produce a high amplitude signal. The presence of electrodes at the mature stage does not have a negative impact on the regeneration, reinnervation and maturation of the RPNI. The electrode leads were passed subcutaneously from the monkey's forearm to the back, where they were passed through the skin to connect to the recording device. Daily recordings from these implanted electrodes were performed during the task behavior. The percutaneous site with the lead that was passed out was gently cleaned with betadine solution every week, and no infection was found. The site looked clean, had little irritation, and did not cause any obvious discomfort to the animal.
[0140] refer to Fig.16 , graph 1600 shows the spontaneous RPNI signal in μV recorded by the semi-chronic Ardiem IM-MES electrode in monkey L, and the calculated flexion percentage corresponding to the RPNI signal. Graph 1602 shows the spontaneous RPNI signal in μV recorded by the transcutaneous fine wire electrode in monkey L, and the calculated flexion percentage corresponding to the RPNI signal. Graph 1604 shows the spontaneous RPNI signal in μV recorded by the transcutaneous fine wire electrode in monkey R, and the calculated flexion percentage corresponding to the RPNI signal.
[0141] Referring to graph 1600, the signals recorded by the IM-MES electrodes vary between animals and RPNI grafts, with amplitudes ranging from 50 μV pp to 500 μV pp. Graphs 1600, 1602, and 1604 show representative signals that appear similar to sparse electromyographic (EMG) signals, which typically show multiple distinct single motor units. The rightmost portion of graph 1600 shows an enlarged portion of the voltage signal, which shows a single muscle twitch. All putative single units observed reliably corresponded to flexion events, were approximately 4 ms in length, and had variable discharge frequencies. The high signal-to-noise ratio (SNR) of the RPNI signal allows the use of a linear discriminant classifier to automatically detect spontaneous RPNI activation with an accuracy of over 95%. The RPNI signal was used to control the prosthetic hand in real time while monkey L performed a behavioral task.
[0142] Example 2
[0143] RPNI studies in humans
[0144] In the following example, three RPNIs were surgically implanted in a human for the purpose of neuroma control. The patient had a distal transradial amputation proximal to the wrist. Multiple muscle grafts of approximately 1×3 cm were removed from the surrounding tissue and sutured to the distal ends of the median, ulnar, and radial nerves, respectively. At this level, the radial nerve (and therefore the RPNI graft) contains only sensory fibers that originally innervated the skin on the back of the hand. The median and ulnar nerves and the RPNI contain a mixture of sensory fibers of the hand and motor fibers that originally innervated the intrinsic muscles of the hand. When the patient performed several hand movements, transcutaneous fine-wire electrodes were used to record the electromyographic (EMG) activity of the median RPNI and ulnar RPNI. As expected, the RPNI generates EMG in response to movements involving muscles that were originally innervated by the severed nerves.
[0145] refer to Fig.17, graphs 1700 and 1702 show signals recorded from the median nerve RPNI, the ulnar nerve RPNI, and a healthy wrist muscle (Flexor Carpi Ulnaris (FCU)) during two different hand movements. Specifically, graph 1700 shows signals recorded during a thumb-pinky finger opposition action, which corresponds to the tip of the thumb touching the tip of the pinky finger. Graph 1702 shows signals recorded during a thumb opposition action, which corresponds to the tip of the thumb touching the base of the pinky finger without flexing the pinky finger. These graphs show that physiologically correct signals are obtained from the RPNI. In other words, the nerve is activated in the correct action.
[0146] As expected, the median RPNI signal (as shown in the top row of graphs 1700 and 1702) shows similar activity amplitude during both thumb-pinky finger opposition and thumb-only opposition. This is because the median nerve originally innervates the thumb muscles rather than the pinky muscles. The ulnar RPNI signal (as shown in the bottom row of graphs 1700 and 1702) is more active during thumb-pinky finger opposition than during thumb-only opposition because the ulnar nerve originally innervates more of the pinky muscles than the thumb. Finally, healthy FCU muscle activity, while clearly present, is not associated with either movement because healthy FCU muscle activity is entirely devoted to wrist flexion.
[0147] Taken together, graphs 1700 and 1702 show that the RPNI is being innervated by the intended nerves, as there should be no way to achieve the same pattern of activity via healthy, intact muscle surrounding the RPNI.
[0148] refer to Fig.18 , graph 1800 shows the signal recorded from the ulnar RPNI during a key pinching motion, which corresponds to pressing the thumb against the side of the index finger to form a fist, i.e., the shape formed when turning a key in a car ignition switch. Graph 1800 illustrates the high signal amplitudes achievable with the RPNI technique. For example, the signal-to-noise ratio (SNR) of the data in graph 1800 is 8.65.
[0149] Example 3
[0150] Studies of continuous positional control in non-human primates
[0151] In the following example, neural signals in the monkey are sensed and monitored as the monkey flexes and extends its fingers. These neural signals are processed using the techniques described above with reference to this teaching (including the use of a Kalman filter), and the flexion percentage is predicted based on these neural signals. In addition, the actual flexion percentage of the monkey's fingers is monitored and compared with the predicted flexion percentage.
[0152] refer to Fig.19 , graph 1900 shows the predicted flexion percentage 1902 of the finger plotted over time, and the actual observed flexion percentage. In graph 1900, the predicted flexion percentage 1902 is correlated with the actual flexion percentage 1904 with a correlation coefficient of 0.87. Graph 1900 shows the accuracy of the techniques described above with reference to the present teaching (including the use of a Kalman filter) in predicting the actual flexion percentage based on monitored neural signals. In this way, the techniques of the present teaching can be used for continuous position control of a prosthesis. In other words, the present teaching can be used to process neural signals and control a prosthesis through a series of flexion positions, rather than discrete prosthesis positions or prosthesis states (e.g., a flexed state or an extended state).
[0153] refer to Figures 20 to 30 , additional embodiments of the present disclosure are shown and include systems and methods for controlling a prosthesis based on amplified neural signals. Fig. 20 , a system 200 for controlling a prosthetic device such as a prosthetic hand 110 is shown. Although the example of the prosthetic hand 110 is used to describe the system 200, other suitable prosthetic devices may also be used. Similar to the above-described systems and methods, the system 200 includes a neural interface system 4 having an implant device 20, as described above, which receives a neural signal from a nerve 6 (e.g., a peripheral nerve) that has been amplified by a free tissue graft 10. The signal is transmitted via an electrical conductor 18 (e.g., as described above with reference to FIG. 1 ). Figure 1 The described guide wires 18a, 18b, 18c) are conveyed from the free tissue graft 10 to the implantation device 20. For example, referring to Figures 1 to 7 An implant device 20, leads 18a, 18b, 18c, a free tissue graft 10, a prosthetic hand 110, and a neural interface system 4 for amplifying neural signals from nerves 6 are depicted.
[0154] As described in more detail below, system 200 is similar to the above referenced Figures 1 to 7 The system described is that the implant device 20 of the system 200 wirelessly transmits data about the amplified neural signals, such as processed EMG data, to the prosthesis controller 220. The prosthesis controller 220 is similar to the one described above with reference to Figure 1 , Figure 3 , Figures 5 to 7 as well as Fig. 9 In the same manner as described above, the implant device 20 controls the prosthetic hand 110, based on the signal received from the implant device 20 to control the prosthetic hand 110 (such as Figure 3 ) actuator 112 as shown.
[0155] Thus, the present disclosure provides systems and methods for controlling a prosthetic hand 110 using amplified neural signals from a free tissue graft 10. The systems and methods of the present disclosure provide intuitive functional control of a multi-joint prosthetic hand for upper limb amputees who have undergone a regenerative peripheral nerve interface (RPNI) surgical procedure. As described above, the RPNI surgical procedure places a separate smaller muscle graft or free tissue graft 10 on the ends of a nerve bundle in the residual limb. The nerve bundle reinnerves its corresponding muscle graft to form a healthy, stable and durable neuromuscular connection. The intramuscular bipolar electrodes, which will be further described below, can be used to record directly from the RPNI. Although the present disclosure describes an example embodiment utilizing RPNI, the systems and methods of the present disclosure can also be used for patients who have undergone a targeted muscle reinnervation (TMR) surgical procedure. The TMR procedure involves transferring residual nerves from an amputated limb to reinnervate a new target muscle that originally lost its function. Then, the reinnervated target muscle acts as a biological amplifier of the truncated neuromotor signal. The electrodes can then be attached or embedded in the target muscle and connected to the implant device 20 of the present disclosure, which can receive nerve signals generated by the reinnervated nerves in the target muscle and process these signals according to the present disclosure to control the prosthetic device. In addition, as described below, the implant device 20 can transmit signals to the reinnervated nerves in the target muscle to provide sensory feedback stimulation. In this way, the systems and methods of the present disclosure, including the implant device 20, can be used for patients who have undergone RPNI and patients who have undergone TMR procedures.
[0156] As described above, the device is a fully implantable recording system that can wirelessly transmit electromyographic (EMG) signals to an external device (e.g., a prosthesis controller 220) for upper limb prosthesis control. For example, the system may include the following reference Figures 20 to 30Further described in detail: (1) implantable electrodes and electrical leads 18; (2) implantable sensing unit, such as implant device 20; (3) wireless transmitter, such as included in the communication circuit 50 of implant device 20; (4) wireless receiver, such as included in the communication circuit 222 of prosthesis controller 220; (5) external smart link controller, such as prosthesis controller 220; and (6) charging unit, such as external programmer charger 280 and inductive charging pad 282. As a further example, implant device 20 can be implemented by a modified PMA approved spinal cord stimulation device (Nuvetra Algovita, PMA P130028). However, instead of stimulation, the unit can be configured to use electrode leads to record EMG signals from both residual muscle and RPNI. The sensing unit or implant device 20 can wirelessly transmit signals to an external intelligent controller (e.g., a prosthesis controller 220), which will then decode or interpret the EMG signals and send commands to a terminal device 1, such as a myoelectric prosthesis such as the prosthesis 110. Additionally or alternatively, the implant device can be configured as a stimulation device with a receiver to receive signals from a transmitter of the prosthesis controller 220 and output signals to the implantable electrodes / electrical leads 18, which are then amplified by the neural interface system 4 to stimulate the nerves 6. In this way, in addition to sensing neural signals and transmitting signals from the implant device to the prosthesis controller, the systems and methods of the present disclosure can also be used to wirelessly transmit signals from the prosthesis controller 220 to the implant device 20, which are then used to stimulate the nerves 6.
[0157] Additional References Fig.21 , the implant device 20 includes the amplifier 24, processing circuit 22, and communication circuit 50 as described above. The implant device 20 includes a battery 230 connected to the amplifier 24, processing circuit 22, and communication circuit 50. Although Fig.21A single amplifier 24 is shown in FIG, but additional amplifiers may be used as described below. The implant device 20 receives an amplified neural signal 240 from the free tissue graft 10 via the electrical lead 18. As described in more detail below, the implant device 20 processes the amplified neural signal and wirelessly transmits data about the amplified neural signal, such as processed EMG data, to the prosthesis controller 220 via the communication circuit 50. For example, the communication circuit 50 includes a wireless transmitter configured for wireless communication. The prosthesis controller 220 includes a communication circuit 222, which includes, for example, a wireless receiver configured for wireless communication. Wireless communication between the communication circuit 50 of the implant device 20 and the communication circuit 222 of the prosthesis controller 220 may be performed using the Medical Implant Communication Service (MICS) protocol and / or the Medical Device Radiocommunication Service (MedRadio) protocol. Additionally or alternatively, any other suitable wireless communication protocol may be used, including, for example, Bluetooth, Bluetooth Low Energy (BLE), WiFi, near-field communication (NFC), or other suitable wireless communication protocols.
[0158] The processing circuit 224 of the prosthesis controller 220 is configured to process the signal received from the implant device 20 by the communication circuit 222 and transmit the signal to the prosthetic hand 110 (such as Figure 3 ) controls the actuator 112 to transmit the prosthesis control signal output 56. For example, the processing circuit 224 of the prosthesis controller 220 may execute the above reference Fig. 9 The control algorithm 900 described above is used to control the prosthesis based on the received signal from the free tissue graft 10. Additionally or alternatively, as described above, the prosthesis controller 220 is also configured to process stimulation feedback signal inputs, such as prosthesis sensor input signals 58 generated by one or more pressure sensors 225 corresponding to the pressure sensed by the pressure sensor 225 of the prosthetic hand 110. For example, when the prosthetic hand 110 grasps an object, the pressure sensor 225 detects the pressure generated by the grasped object. The prosthesis sensor input signals 58 can be received via a data communication bus such as a CAN bus 226 and processed by the processing circuit 224 of the prosthesis controller 220, which can then transmit the stimulation / sensory feedback signal to the implant device 20 via wireless communication transmitted from the communication circuit 222 to the communication circuit 50.
[0159] refer to Fig. 22 , four electrical leads 18 are shown, wherein each electrical lead 18 includes two wires connected to a positive electrode 252 and a negative electrode 254, respectively. Fig.23 A photograph showing the electrical lead 18, the positive surface of the positive electrode 252, and the negative surface of the negative electrode 254 is shown. Fig. 22 In the example of FIG. 1 , eight wires of the electrical lead 18 are connected to the eight-contact connector 250. Specifically, as Fig. 22 As shown, the eight contact wires of the eight-contact connector 250 are connected to the exposed wires of the electrical leads 18 using, for example, platinum crimp connectors, which are then sealed with silicone tubing. Fig. 22 The example in Figure 2 utilizes a platinum compression connector with silicone tubing to connect the contact wires of the eight-contact connector 250 to the exposed wires of the electrical leads 18, but any other suitable method for connecting the contact wires of the eight-contact connector 250 to the exposed wires of the electrical leads 18 may be used. Alternatively, the exposed wires of the electrical leads 18 may be directly connected to the contacts of the eight-contact connector 250. In addition, although Fig. 22 The example in Figure 2 utilizes four two-conductor electrical leads 18 and an eight-contact connector 250, but any other suitable number of conductors, electrical leads, and contact connectors may be used. For example, the contact connector may include contacts for receiving two, four, six, ten, twelve, or any other suitable number of conductors, and the electrical leads may include two, four, six, ten, twelve, or any other suitable number of conductors.
[0160] To record EMG signals from residual muscle and RPNI, the system 200 utilizes an assembly of electrodes and leads that connect muscle tissue (e.g., free tissue graft 10) to an implant device 20. The assembly can include a modified version of existing bipolar electrodes, and a modified version of existing cable leads connected to the implant device 20. For example, each implant device 20 can be connected to twelve bipolar electrodes, each lead comprising eight contacts, and each implant device 20 has three leads. The bipolar electrodes can be modified from the PermaLocTM electrodes that have been approved by the U.S. Food and Drug Administration (FDA) as part of the long-term implant system NeuRx Diaphragm Pacing System. Fig.23 As shown, the bipolar electrode has an additional deinsulated lead surface compared to the monopolar PermaLocTM electrode, and the plastic tinned anchor at the distal end of the electrode has been removed. The basic design, all material components and sterilization procedures remain the same. The electrode can be implanted percutaneously in patients with upper limb amputations, for example, to record EMG signals from residual muscle and RPNI.
[0161] Several modifications and additions were made to allow the bipolar electrodes to be fully implanted and connected to the implant device 20. To connect to the implant device 20, an industry standard Bal Seal connector lead manufactured by Cirtec Biomedical, Inc. was used. A single Bal Seal connector lead has eight contacts, with eight conductors parallel to the lead body. Other numbers of contacts, such as twelve conductors, may be used. The lead diameter is 0.053 mm, with an estimated impedance of 4 ohms per foot. The conductor material used is MP35N containing 28% silver, and the outer insulation is 55DPellethane, and the conductor insulation is ETFE. The electrical connection to the Bal Seal uses a platinum-iridium connector ring. The bare cable is exposed 10 cm to 15 cm from the proximal end of the Bal Seal connector conductor, and the bare cable at the proximal end of the PermaLoc bipolar lead is exposed. The distal and proximal ends of the two leads are permanently connected to form a single lead with 4 bipolar electrodes. The mating uses platinum compression connectors to connect each individual bare wire, and these platinum compression connectors will be covered with silicone tubing for protection. The protected joints are located as close to the implant device 20 as possible to avoid the intersection of anatomical joints in the patient's body with the thicker parts of the lead. The total length of the assembled lead from the proximal end to the distal end is approximately 100cm to 105cm. Therefore, the distal and proximal ends of two previously approved electrode leads are permanently mated without changing the electrical characteristics or material properties of these leads.
[0162] refer to Fig.24A , the implant device 20 includes a head that receives one or more contact connectors connected to electrical leads. Fig.24A As shown, the implant device includes electrical ports 256, each of which is configured to receive an eight-contact connector 250. Each port 256 can each include a Bal Seal connector, such as a Bal Seal connector manufactured by Cirtec Biomedical, which is configured to seal the implant device 20 once the eight-contact connector 250 is inserted into the electrical port. The implant device also includes a head having parallel conductors 254, which have contacts that are positioned and spaced to correspond to and align with the contacts of the eight-contact connector 250. In this example, the Bal Seal conductors 254 are manufactured by Bal Seal Inc. and are part of the head manufactured by Cirtec. Fig.24A In the example of FIG. 1 , the implant device is configured with a head having three parallel conductors 254 for receiving three eight-contact connectors 250. In this manner, Fig.24AThe implant device 20 shown can accommodate signals from up to 24 wires, i.e., signals from three groups of eight wires based on signals from 24 electrodes, including twelve positive electrodes 252 and twelve negative electrodes 254. The twelve positive electrodes 252 and twelve negative electrodes 254 enable the implant device 20 to receive twelve bipolar channels of EMG activity based on the amplified neural signals 240 from the free tissue graft 10. Although Fig.24A The example of utilizes 24 wires and 24 electrodes, but the implant device 20 can be configured with a head and parallel conductors 254 for accommodating any number of wires and electrodes. For example, the implant device 20 can include a head with two sets of parallel conductors 254, each of which includes 12 contacts to receive a twelve-contact connector. Alternatively, the implant device 20 can include four sets of parallel conductors 254 to receive four eight-contact connectors 250, thereby receiving signals from four sets of electrical leads based on signals from 32 electrodes, including 16 positive electrodes 252 and 16 negative electrodes 254. In this way, the implant device 20 can include a head with any suitable number of parallel conductors 254, which have any number of contacts to receive a contact connector with any number of wires.
[0163] The implant device 20 can be implemented using a modified implantable recording device based on the Algovita platform developed by Cirtec Biomedical. The Algovita platform (PMA P130028) is an FDA-approved implantable pulse generator for reducing pain via spinal cord stimulation. The electrode leads are connected to the implant device 20 using a head with 3 rows, each row containing 8 spring platinum iridium Bal Seals. The leads are secured after implantation with titanium set screws, which are tightened with a torque wrench inserted into the diaphragm. Algovita is internally powered by a 4.1V lithium-ion battery with a nominal capacity of 215 milliampere hours (mAh). After testing, the lithium-ion battery still maintains capacity after 1000 discharge cycles. The lithium-ion battery also has a low self-discharge rate, so shelf life is not a problem for this application because the battery exceeds the shelf life of the sterile packaging. The implant device 20 communicates wirelessly with external components via a medical implant communication system (MICS) having a communication circuit 50, which may include, for example, a Microsemi ZL70323MNJ, a newer version of the MICS chip used in the original Algovita. MICS communications use the 2.45 Gigahertz (GHz) band for wake-up and the 402 MHz to 405 MHz band for data transmission. In addition to the updated MICS chip, the battery, power management, and communication circuits remain unchanged.
[0164] The external physical design of the implant device 20 remains the same as the Algovita device. The internal component changes to convert the Algovita into a sensing device are limited. The Saturn stimulator application-specific integrated circuit (ASIC) was replaced by the Intan RHD2216 amplifier for sensing biopotentials rather than stimulating neural tissue. The Intan amplifier has low power consumption and has been previously used in surgical invasive clinical studies. No adverse reactions were found in these acute studies. As an example, a linear voltage regulator (TPS7A2033 from Texas Instruments) can take a 4.1V battery voltage as an input and convert the battery voltage to a 3.3V signal to power the RHD2216. The (MicroSemi's ZL70321MNJ) MICS module on the Algovita was replaced with a newer version, the ZL70323MNJ, from MicroSemi.
[0165] refer to Fig. 24B, shows another embodiment having an alternative arrangement of six electrical leads 18' including six bipolar electrodes connected to a twelve-contact connector 250'. Similar to the above reference Figures 22 to 24A In the configuration described, the twelve-contact connector 250' can be received by the head of the implant device 20. As described above, the port 256 of the implant device 20 can include a Bal Seal connector, such as a Bal Seal connector manufactured by Cirtec Biomedical, which is configured to seal the implant device 20 once the twelve-contact connector 250' is inserted into the electrical port of the implant device 20. The contacts of the twelve-contact connector 250' are sufficiently spaced to match the spacing of corresponding connectors on the head of the implant device 20. In addition, in the embodiment of Figure 24, a triangular coupling device 251 is utilized to receive six electrical leads 18' and couple these six electrical leads 18' to the twelve-contact connector 250'. As shown Fig. 24B As shown, coupling device 251 includes parallel connections for six electrical leads 18' on the wider portion of the triangular coupling device 251 and couples twelve wires of six bipolar electrodes to a single cable, where each of the twelve wires is connected to a separate contact of a twelve-contact connector 250'.
[0166] refer to Fig.25 The implant device 20 includes a protection circuit for protecting the electronic components of the implant device from surge voltages during an electrostatic discharge (ESD) event. For example, the implant device 20 may experience an ESD event when it is manipulated during a surgical procedure to implant the implant device 20 into a patient. For example, Fig.25 As shown, a 220 ohm resistor 262 is located before the input of amplifier 24 to provide protection against surge voltages that may be established in the event of an ESD event. As an example, the 220 ohm resistor 262 may be an AC0603JR-07220RL resistor available from Yageo. As a further example, Fig.25 As shown, amplifier 24 may be an Intan RHD2216 amplifier for sensing biopotentials. Additionally, as a further example, ESD diode 260 may be located on the side of resistor 262 opposite the input of amplifier 24. For example, diode 260 may be an SMS24T1G ESD diode available from ON Semiconductor. Fig.252 shows an ESD protection circuit for one input of the implant device 20, but for each input of the implant device 20, the same protection circuit including the 220 ohm resistor 262 and the ESD diode 260 may be included. In this way, as Figure 21 to Figure 2 4, for an implant device 20 configured with a head having three sets of contactors 254 for three sets of eight-contact connectors 250 (i.e., a total of 24 inputs), the implant device 20 may include 24 sets of Fig.25 In other words, for each of the two inputs of the implant device 20, the implant device 20 may include a 220 ohm resistor 262 and an ESD diode 260. Fig.25 Specific examples of resistor 262 and diode 260 are shown in FIG. 2 , but any other suitable resistor and diode may be used in the protection circuit to protect implant device 20 from ESD events.
[0167] refer to Fig.26 , shows a functional block diagram of a system and method for processing amplified neural signals according to the present disclosure. Fig.26 As shown, the original amplified neural signal 240 is received by the implant device 20. For example, Figure 21 to Figure 2 4 and as described above, the implant device 20 receives EMG activity from twelve bipolar channels of the implanted electrodes and electrical leads 18. At 270, the amplified neural signals are filtered using a 100 Hz to 500 Hz bandpass filter, which has been shown to provide an accurate measurement of EMG activity. At 272, the filtered signals are then sampled by the processing circuit 22 of the implant device 20 at a Nyquist rate of approximately 1 kHz to produce EMG data at approximately 1 kilosamples per second (1 KSps). At 274, the processing circuit 22 of the implant device 20 then calculates the mean-absolute-value (MAV) of the activity of each bipolar channel. At 276, the processing circuit 22 uses the communication circuit 50 of the implant device 20 to wirelessly transmit the MAV of the activity of each bipolar channel to the communication circuit 222 of the prosthesis controller 220 using the MICS protocol.
[0168] As described above, in order to wirelessly send data to and receive data from non-implanted devices such as a prosthesis controller 220 or another external communication device, the implant device 20 can use the communication circuit 50 of the existing MicroSemi MICS communication device from the Algovita platform. After implantation, the device can be turned on / off by waving a magnet on the implant device 20. When the implant device 20 is running, the implant device can interact with the following two external devices: the programmer charger discussed below; and the prosthesis controller 220, also known as the Smart Link Controller (SLC). As described above, the implant device 20 is configured to wirelessly stream EMG to the prosthesis controller 220. The implant device 20 includes a boot loader for wireless firmware updates. The microcontroller of the implant device 20 is the MSP430F2618 (MSP430) from Texas Instruments, which is also used for the Algovita platform. The microcontroller is programmed to use the IntanRHD2216 amplifier to record EMG activity from 12 bipolar channels of the implanted electrodes.
[0169] In this manner, rather than sending raw EMG data to the prosthesis controller 220, the implant device 20 first filters, samples, and processes the raw EMG signals from the bipolar channels to first calculate the MAV of the sampled EMG signals for each bipolar channel, and then wirelessly transmits only the processed MAV data for each bipolar channel to the prosthesis controller 220. This configuration provides a technical advantage of maximizing the battery life of the battery 230 of the implant device 20 and the battery life of the power source of the prosthesis itself, since streaming the higher bandwidth raw EMG signals directly from the implant device 20 to the prosthesis controller 220 would require more power. In this manner, the systems and methods of the present disclosure maximize the battery life of the device by first filtering, sampling, and processing the raw EMG data at the implant device 20, and then wirelessly transmitting only the processed EMG signals for each bipolar channel to the prosthesis controller 220.
[0170] refer to Fig. 27 , shows examples of a prosthesis controller 220 both external to the prosthetic hand 110 and mounted internally to the prosthetic hand 110 . Fig. 27 A quarter is also shown in the figure to illustrate the relative size and proportions of the prosthetic controller 220. Fig. 27 As shown in , the prosthesis controller 220 may be implemented using a printed circuit board assembly (PCBA).
[0171] The prosthesis controller 220 receives the processed EMG data packets and decodes them into movement commands for the prosthesis. For example, the prosthesis controller 220 includes a communication circuit 222, which may include a ZL70123 chip, for example, to communicate wirelessly and securely with the implant device 20 using the standard MICS protocol. All components of the prosthesis controller 220 are soldered on the PCBA, and the device is enclosed in a waterproof housing within the prosthesis. The materials used in the prosthesis controller 220 are commonly used in modern PCBAs. The circuit board is a flat laminated composite material with internal copper circuits. The components mounted on the circuit board are application specific integrated circuits (ASICS) that the manufacturer intends to use. The ASICS utilizes industry-standard surface mount technology and is attached to the circuit board using lead-free solder.
[0172] As described above, the prosthesis controller uses state-of-the-art algorithms, including machine learning algorithms, to decode EMG signals into motor commands. The choice of algorithm depends on the operating mode of the prosthetic hand. Classifiers can be used to decode the grasp for intuitive grasp selection, with additional gain for proportional control. Alternatively, regressors can be used to control individual fingers simultaneously and independently.
[0173] The prosthesis controller can be connected to a laptop computer (e.g., an external programmer device 290 described below) to record processed EMG from the implant device 20. As described below, the implant device 20 can also be wirelessly connected to a laptop computer (e.g., an external programmer device 290) and communicate with the laptop computer. The recorded EMG can be used to measure the signal strength from each electrode pair and calculate the decoding parameters. The configuration mode can be used to load new parameters onto the prosthesis controller 220. The test mode can be used to verify the prosthesis controller function of the implant device 20. In the test mode, the external programmer device 290 can transmit pre-recorded EMG data packets to the prosthesis controller, and the prosthesis controller will respond with decoded motion commands. In other aspects, the device operation is fixed and includes: receiving signals; decoding expected movements; and sending outputs to the prosthesis.
[0174] The power of the prosthesis controller 220 is provided by the battery of the prosthesis. Once the prosthesis controller 220 is activated, it automatically connects to the prosthesis 110 and waits to receive a signal from the implant device 20. When the prosthesis controller 220 does not receive a signal from the implant device 20, the prosthesis controller will stop sending predictions of movement to the prosthesis 110. This will prevent unexpected or unpredictable movement of the prosthesis.
[0175] refer to Fig.28, an external programmer charger 280 and an inductive charging pad 282 are shown for charging the implant device 20. To charge the implant device 20 after it is surgically implanted into the patient's body, the inductive charging pad 282 can be directed toward the patient at a location close to the implant device 20 inside the patient's body. For example, if the implant device 20 is Fig. 20 20 is implanted in the patient's chest as shown, the inductive charging pad 282 can be placed on the patient's chest, located above the approximate location of the implant device 20 within the patient's chest. The external programmer charger 280 and / or the inductive charging pad 282 can generate an output, such as lighting an output light emitting diode (LED) or generating an audible sound, to indicate that the inductive charging pad 282 and the implant device 20 are aligned for inductive charging. Once aligned and communicating, the external programmer charger 280 and the inductive charging pad 282 can charge the battery 230 of the implant device 20 while the implant device 20 is implanted inside the patient's body. The same patient programmer charger (PPC) from the Algovita platform can be used to wirelessly charge the internal battery of the ISU using inductive coupling at 40kHz, 0.65 watts (W). The PPC can also be used to check the battery charge of the ISU.
[0176] refer to Fig.29, an external programmer device 290 is shown in communication with the communication circuit 50 of the implant device 20 and the communication circuit 222 of the prosthesis controller 220. When the implant device 20 is implanted in the patient's body, the communication between the external programmer device 290 and the communication circuit 50 of the implant device 20 can be performed wirelessly. The communication between the external programmer device 290 and the communication circuit 222 of the prosthesis controller 220 can be performed wirelessly or via a wired communication connection. The external programmer device 290 can be implemented with a computing device, such as a laptop computer, a desktop computer, a tablet device, a mobile device, or any other suitable computing device configured with an application configured to communicate with the implant device 20 and the prosthesis controller 220. For example, as described above, the external programmer device 290 can receive an EMG signal of the amplified neural signal 240 from the implant device 20, including a raw EMG signal or a filtered, processed, and sampled EMG signal. As a further example, the external programmer device 290 may use the filtered, processed, and sampled EMG signals from the implanted device 20 to determine configuration parameters of the prosthesis controller 220. Additionally or alternatively, the external programmer device 290 may receive the filtered, processed, and sampled EMG signals from the communication circuit 222 of the prosthesis controller 220 after the filtered, processed, and sampled EMG signals are received from the implanted device 20. The external programmer device 290 may then determine the configuration parameters to be used by the prosthesis controller 220 to control the prosthetic hand 110 based on the filtered, processed, and sampled EMG signals from the implanted device 20. The external programmer device 290 and / or the prosthesis controller 220 may also use a machine learning algorithm to determine and adjust the configuration parameters to be used by the prosthesis controller 220 to control the prosthetic hand 110 based on the filtered, processed, and sampled EMG signals from the implanted device 20.
[0177] refer to Fig.30 , showing another embodiment of the present disclosure. Fig.30 The system 300 is similar to the system 200 described above, except that the system 300 does not include the implant device 20 implanted into the patient. Fig.30 The system 300 is configured for testing and configuring the implant device 20 before it is implanted in a patient. Similar to the system 200 described above, the system 300 includes a neural interface system 4 having a neural signal from a nerve 6 (e.g., a peripheral nerve) that has been amplified by a free tissue graft 10. However, in Fig.30In the system 300, the electrical leads 18 extend outside the patient's body through the port 302 and connect to the interface 304. The interface 304 is connected to the external programmer device 290, which communicates with the prosthesis controller 220 of the prosthetic hand 110. The system 300 can be used to test and calibrate the parameters of the prosthesis controller 220 before the implant device 20 is implanted inside the patient's body, and with the prosthetic hand 110 attached to or not attached to the patient. In this way, the system 300 can be used to examine and analyze the neural signals generated by the nerves 6 and amplified by the free tissue graft 10 to determine whether these signals are sufficient for the prosthesis controller 220 to control the prosthetic hand 110 before the implant device is implanted in the patient's body.
[0178] As described above, the implant device 20 of the present disclosure can be used to generate a prosthesis control signal output 56 for controlling a prosthesis device (e.g., a prosthetic hand 110), and can also be used to receive stimulation feedback signals, such as a prosthesis sensor input signal 58 generated by one or more pressure sensors 225, which are used to provide stimulation to the nerve 6 and sense feedback signals. For example, the implant device 20 may include one or more Intan RHS2116 stimulator / amplifier chips configured to stimulate neural tissue and sense biopotentials. The RHS2116 stimulator / amplifier chip provides current-controlled stimulation pulses of up to 2.55 milliamps (milliamp, mA) to individual electrode contacts, which have been shown to be sufficient to cause sensor perception. The stimulation pulses can be delivered in a two-phase manner to achieve charge balance. The RHS2116 stimulator / amplifier chip has a fast amplifier reset function to eliminate stimulation artifacts before sensing biopotentials. The RHS2116 stimulator / amplifier chip can be powered by a 3.3 volt linear voltage regulator (e.g., TPS7A2033 from Texas Instruments). Additionally or alternatively, a bipolar output power supply may be used to provide positive and negative voltage supplies of up to plus or minus 7 volts (+ / - 7V) for stimulating the RHS2116 stimulator / amplifier chip.
[0179] In one embodiment, the systems and methods of the present disclosure may be used to both: (1) receive signals from a free tissue graft to generate a prosthesis control signal output 56 for controlling a prosthetic device (e.g., a prosthetic hand 110); and (2) receive stimulation and sensory feedback signals, such as a prosthesis sensor input signal 58 generated by one or more pressure sensors 225 of a prosthetic device (e.g., a prosthetic hand 110). However, one problem with performing both motion control functions and sensory perception / stimulation functions at the same time is that the stimulation signal may produce artifacts or noise in the signal being sensed and recorded for motion control of the prosthetic device. Therefore, the implant device 20 of the present disclosure is configured to use the following reference Figure 31 to Figure 33One or more of the described methods and algorithms to mitigate and / or eliminate signal corruption and artifact issues, Figure 31 to Figure 33 Various methods and algorithms are presented for mitigating and / or eliminating signal corruption and artifacts in sensed and recorded signals used for motion control of a prosthetic device.
[0180] For example, refer to Fig.31 , shows an algorithm for generating prosthetic movement commands and performing stimulation in alternating time periods. Figure 31 to Figure 33 , time periods t-3, t-2, t-1, and t are shown from left to right along the horizontal axis. The time period can be, for example, a time period of 10 milliseconds to 50 milliseconds, but any suitable time period length can be used. In addition, X represents the prosthesis motion command generated by the implant device 20 during the time period indicated by the subscript. In addition, Y represents the EMG signal received from the electrodes implanted or attached to the RPNI, residual muscle and / or target muscle during the time period indicated by the subscript after the TMR surgery. In time period t-3, the stimulation function is initially turned off, and the implant device 20 generates a prosthesis motion command based on the EMG signal Y. t-3 Generate prosthesis motion command X t-3 At time period t-2, a stimulation event is detected that lasts throughout time periods t-2, t-1, and 5 in the example. For example, the stimulation event may be a signal received from a pressure sensor 225 of the prosthetic device. In other words, once a need to provide stimulation for sensor perception is detected (e.g., when the pressure sensor 225 detects an increase in pressure on the prosthetic device and generates a pressure signal), stimulation may be initiated and used.
[0181] exist Fig.31 In the method and algorithm shown, the implant device 20 alternates between performing sensory stimulation and generating prosthetic movement commands during consecutive time periods. For example, when the stimulation function is turned on during time periods t-2 and t, sensory stimulation is performed; during time periods t-3 and t-1, the stimulation function is turned off and the prosthetic movement commands are generated based on the EMG signal Y. t-3 and Y t-1 Generate prosthesis motion command X t-2 and X t-1 In this way, prosthetic movement commands are generated during time period t-3 and time period t-1, and stimulation of sensory perception is performed during time period t-2 and time period t. In this way, generation of prosthetic movement commands is temporarily suspended during time period t-2 and time period t, while stimulation is performed. Similarly, stimulation is temporarily suspended during time period t-3 and time period t-1, while prosthetic movement commands are generated. Fig.31In the example of , after applying the stimulus and then moving to the next time period (e.g., t-1) for generating prosthetic motion commands, the position of the prosthesis and / or the state of the prosthetic commands are in the same position or state as at the end of the previous time period (e.g., t-3) for generating prosthetic motion commands. In other words, Fig.31 In the method and algorithm of , the implant device 20 alternates time windows between: (A) generating prosthesis motion commands X when stimulation is off; and (B) pausing prosthesis control when stimulation is on. In this way, the implant device 20 switches back and forth between receiving stimulation and sending control signals at each time period (e.g., every 10 milliseconds to 50 milliseconds).
[0182] exist Fig.31 In the method and algorithm of , the prosthesis motion command is not updated during the stimulation time period (e.g., t-2 and t). In other words, if the prosthesis motion command at the end of time period t-3 is to command the prosthetic hand 110 to move according to command X t-3 If the speed is closed at the indicated speed, then at the beginning of time period t-1, the artificial hand will still close at the previous command X t-3 The method and algorithm can be implemented with a variety of control algorithms, including: regressors that estimate kinematics, such as linear regression or neural networks; or classifiers that estimate discrete states, such as linear discriminant analysis, naive Bayes, support vector machines, and / or neural networks.
[0183] refer to Fig.32 , another algorithm for generating prosthetic movement commands and executing stimulation is shown. Fig.32 The method and algorithm shown in are similar to those in reference Fig.31 The methods and algorithms shown are just Fig.32 The method and algorithm shown in Figure 1 estimate the prosthesis motion command during the time period of performing stimulation. For example, in time period t-2 and time period t, the implant device 20 estimates the prosthesis motion command based on the previously generated prosthesis motion command (e.g., X t-3 and X t-1 ) to generate the estimated prosthesis motion command X t-2 and X t .For example, Fig.32 The methods and algorithms in this paper are not simply (as shown by Fig.31The method and algorithm described in the present invention (as performed by the method and algorithm in the present invention) does not suspend the generation of prosthesis motion commands during the stimulation time period, but instead provides estimated prosthesis motion commands in time period t-2 and time period t, for example, to provide a smoother transition for generating prosthesis commands in time period t-3 and time period t-1. The method and algorithm can utilize a recursive algorithm or regression algorithm that estimates kinematics (such as a Kalman filter or a particle filter) or utilize a classifier that estimates discrete states (such as a Markov model). In this way, the implant device 20 uses both the incoming signal measurements and the mathematical process model to recursively estimate the motion state over time. Similar to Fig.31 The method in Fig.32 The method in alternates between sensing and receiving signals from the electrodes (e.g., in time periods t-3 and t-1) and sending stimulation signals for sensing sensations (e.g., in time periods 5-2 and 5). In addition, the implant device 20 does not read or sense any signals from the electrodes when performing stimulation, e.g., during time periods t-2 and 5. However, the implant device 20 can generate the estimated prosthesis motion commands (e.g., X t-2 and X t ) to provide a smoother series of commands over time, rather than pausing to generate prosthesis movement commands during periods of stimulation. Fig.32 The methods and algorithms in the above can be used in two consecutively generated commands (e.g., X t-3 and X t-1 ) and avoids pausing the build command Fig.31 The methods and algorithms in the above example can be used to jump between commands. Fig.32 The methods and algorithms can adapt to intermittent measurements and provide smooth command updates during the period of time when sensory perception stimulation is performed.
[0184] refer to Fig.33 , shows another algorithm for generating prosthetic movement commands and performing stimulation. Fig.33 In the method and algorithm, prosthesis motion commands are generated in all time periods. However, during time periods (e.g., t-2 and t) in which stimulation is also performed, the implant device 20 performs artifact estimation to estimate the artifacts introduced into the EMG signal Y from the electrode due to stimulation, and then subtracts or filters out the estimated artifacts from the EMG signal Y, and generates the prosthesis motion command X based on the result / filtered EMG signal obtained after the artifact subtraction. In this way, the implant device 20 can remove artifacts that may be introduced into the EMG signal due to the performance of stimulation while reading the neural signals from the electrodes attached to the free tissue graft 10. In other words, the implant device performs noise reduction, filtering, or elimination on the EMG signal Y to remove artifacts that may have been introduced into the signal by performing sensory perception stimulation.
[0185] For example, a template subtraction algorithm can be used to generate expected artifacts based on a given stimulus signal or a set of stimulus signals. The template can be used to subtract artifacts from the EMG signal. In other words, under this method, the EMG signal Y may be corrupted by the stimulation of sensory perception, but the algorithm or method filters the EMG signal Y to subtract artifacts, so that the prosthesis movement command can be generated based on the filtered EMG signal Y. For example, the template subtraction algorithm can be implemented by using multiple exponential filters with filtering learning rates to calculate the average of the artifacts immediately following the stimulation pulse. In this way, a representative template can be constructed and then subtracted from the original signal to produce an estimated artifact-free signal.
[0186] Additionally or alternatively, an ε-normalized least mean square algorithm can be used to remove unwanted artifacts from the EMG signal Y. For example, the ε-normalized least mean square algorithm can be implemented as an improved version of the standard least mean square algorithm, producing better performance for signals with larger and lower signal energy intervals. In the ε-normalized least mean square algorithm, adaptive filtering relies on a reference signal that is highly correlated with the stimulation artifact. The algorithm can adapt to different artifact waveforms without completely relearning the weights used by the algorithm. For example, the ε-normalized least mean square adaptive filtering algorithm convolves a reference signal with the filter weights to predict the artifact waveform. The predicted artifact is subtracted from the original signal to produce an estimated artifact-free signal, which is then also used to update the filter weights after each sampling.
[0187] although Fig.33 The example in shows that stimulation is performed in alternating time periods, but stimulation may also be performed continuously in consecutive time periods while reading the EMG signal Y and filtering / subtracting any artifacts introduced into the EMG signal Y. Fig.33 As shown in the example of , stimulation can be performed in alternating time periods to conserve battery power of the implant device 20.
[0188] Although you can use Figure 31 to Figure 33 The implant device 20 may alternatively be configured to execute all three methods and / or switch between the methods to determine and select the best method or algorithm for a particular environment or scenario.
[0189] although Figure 31 to Figure 33 A method of performing sensory perceptual stimulation in alternating time periods is shown, but another order may be used instead. For example, stimulation may be performed in two or more consecutive time periods, followed by reading the EMG signal Y in one or more time periods to generate prosthetic movement commands.
[0190] Non-limiting discussion of terms
[0191] The foregoing description of each embodiment has been provided for the purpose of illustration and description. This description is not intended to be exhaustive or to limit the present disclosure. The individual elements or features of a particular embodiment are generally not limited to that particular embodiment, but where applicable, these elements and features are interchangeable and can be used in the selected embodiment even if not specifically shown or described. The same situation can also be changed in many ways. This variation should not be considered as departing from the present disclosure, and all such modifications are intended to be included in the scope of the present disclosure. Example embodiments are provided so that the present disclosure will be thorough and the scope will be fully conveyed to those skilled in the art. Many specific details, such as examples of specific components, equipment and methods, are set forth to provide a thorough understanding of the various embodiments of the present disclosure. It will be apparent to those skilled in the art that specific details do not need to be adopted, and each example embodiment can be implemented in many different forms, and neither of these should be interpreted as limiting the scope of the present disclosure. In some example embodiments, well-known processes, well-known equipment structures, and well-known technologies are not described in detail.
[0192] As used herein, the term circuitry may refer to, be part of, or include an application specific integrated circuit (ASIC); an electronic circuit; a combinational logic circuit; a field programmable gate array (FPGA); a processor (shared processor, dedicated processor, or processor group) that executes code; other suitable hardware components that provide the described functionality; or a combination of some or all of the above, such as in a system on a chip. The term circuitry may include a memory (shared memory, dedicated memory, or memory group) that stores code executed by a processor.
[0193] As used above, the term code may include software, firmware and / or microcode, and may refer to a program, a routine, a function, a class and / or an object. As used above, the term sharing means that some or all codes from multiple circuits can be executed using a single (shared) processor. In addition, some or all codes from multiple circuits can be stored by a single (shared) memory. As used above, the term group means that some or all codes from a single circuit can be executed using a group of processors. In addition, some or all codes from a single circuit can be stored using a group of memories.
[0194] The apparatus and methods described herein may be implemented by one or more computer programs executed by one or more processors. The computer program includes processor executable instructions stored on a non-transitory tangible computer readable medium. The computer program may also include stored data. Non-limiting examples of non-transitory tangible computer readable media are non-volatile memory, magnetic storage devices, and optical storage devices.
[0195] The headings (e.g., "Background" and "Summary") and subheadings used herein are intended only for general organization of the various topics within the disclosure and are not intended to limit the disclosure or any aspect of the disclosure. Specifically, the subject matter disclosed in the "Background" may include novel technologies and may not constitute a statement of the prior art. The subject matter disclosed in the "Summary" is not an exhaustive or complete disclosure of the full scope of the technology or any embodiment of the technology. Classification or discussion of a material as having a particular use within a portion of this specification is done for convenience and should not be inferred that when the material is used in any given composition, the material must or exclusively function according to its classification herein.
[0196] The disclosures of all patents and patent applications cited or referenced in this disclosure are hereby incorporated by reference.
[0197] Although the description and specific examples indicate features and embodiments, they are for illustrative purposes only and are not intended to limit the scope of the present disclosure. In addition, listing multiple embodiments having the described features is not intended to exclude other embodiments having additional features, or other embodiments incorporating different combinations of the described features. Specific examples are provided for the purpose of illustrating how to perform and use the described methods, systems, and compositions, and unless otherwise expressly stated, these specific examples are not intended to indicate that a given embodiment has been performed or tested, or has not been performed or tested.
[0198] As used herein, the words "preferred" or "preferred" refer to embodiments that provide certain benefits in certain circumstances. However, other embodiments may also be preferred under the same or other circumstances. In addition, the listing of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the present disclosure.
[0199] As used herein, the word "include" and its variations are intended to be non-limiting, such that enumeration of items in a list does not exclude other similar items that may also be useful in the described methods, systems, materials, compositions, and apparatuses. Similarly, the terms "may" and "might" and their variations are intended to be non-limiting, such that a statement that an embodiment may or may include certain elements or features does not exclude other embodiments that do not include those elements or features.
[0200] Although the open-ended term "comprising" is used herein as a synonym for non-limiting terms such as including, containing, or having to describe and claim various embodiments of the present disclosure, more restrictive terms such as "consisting of" or "consisting essentially of" may alternatively be used to describe various embodiments. Thus, for any given embodiment in which a material, component, or process step is recited, the present disclosure also specifically includes embodiments consisting of or consisting essentially of such material, component, or process, excluding additional materials, components, or processes (for the case of consisting of such material, component, or process) and excluding additional materials, components, or processes that affect significant properties of the embodiment (for the case of consisting essentially of such material, component, or process), even if such additional materials, components, or processes are not explicitly recited in this application. For example, a statement of a composition or process reciting elements A, B, and C specifically envisions embodiments consisting of A, B, and C as well as embodiments consisting essentially of A, B, and C, excluding element D, which may be recited in the art, even if element D is not explicitly described as being excluded herein.
[0201] As mentioned herein, unless otherwise expressly stated, ranges include endpoints, and include disclosures of all different values and further divided ranges within the entire range. Thus, for example, the range of "from A to B" or "from about A to about B" includes A and B. The disclosure of values and value ranges of specific parameters (such as temperature, molecular weight, weight percentage, etc.) does not exclude other values and value ranges useful herein. As understood by those of ordinary skill in the art, the use of the term "about" for a range, value, or threshold should be considered in the context of the range, value, or threshold. To some extent, it is impossible to determine a range, value, or threshold according to the context, and the use of the term "about" may correspond to a range of ten to fifteen percent. It is envisioned that two or more specific example values of a given parameter may define the endpoints of the value range that may be claimed for the parameter. For example, if parameter X is exemplified herein as having a value A, and is also exemplified as having a value Z, it is envisioned that parameter X may have a value range from about A to about Z. Similarly, it is contemplated that the disclosure of two or more ranges of values for a parameter (whether the ranges are nested, overlapping, or different) includes all possible combinations of ranges of values that may be claimed using the endpoints of the disclosed ranges. For example, if parameter X is exemplified herein as having values in the range of 1 to 10, or 2 to 9, or 3 to 8, it is also contemplated that parameter X may have other ranges of values, including 1 to 9, 1 to 8, 1 to 3, 1 to 2, 2 to 10, 2 to 8, 2 to 3, 3 to 10, and 3 to 9.
Claims
1. A system, include: An implant device having a processing circuit configured to receive electrical signals from a plurality of free tissue grafts surgically attached to nerves of a subject; wherein the electrical signals are received via a plurality of bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the plurality of bipolar electrode pairs being implanted within and in electrical communication with the plurality of free tissue grafts; the plurality of free tissue grafts being surgically attached to the subject such that the plurality of free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the plurality of free tissue grafts being autologous grafts of devascularized and denervated tissue harvested from the subject prior to being surgically attached to the subject; the processing circuit further configured to process the received electrical signals, generate processed signal data, and wirelessly transmit the processed signal data to a prosthesis controller; in: After the plurality of free tissue grafts are surgically attached to the nerve, the nerve reinnervates the plurality of free tissue grafts; The electrical signals from the plurality of free tissue grafts have a voltage amplitude greater than or equal to about 150 microvolts; and The prosthesis controller is configured to control a prosthetic device based on the processed signal data wirelessly transmitted from the processing circuitry of the implanted device.
2. The system according to claim 1, in, The processing circuit is configured to apply a bandpass filter to the received electrical signal and to sample the filtered electrical signal.
3. The system according to claim 2, in, The bandpass filter is a 100 Hz to 500 Hz bandpass filter, and the processing circuit is configured to sample the filtered electrical signal at a sampling rate of 1 kHz.
4. The system according to claim 3, in, The processing circuit is further configured to generate the processed signal data by calculating an average absolute value of the sampled electrical signal, and wirelessly transmit the average absolute value of the sampled electrical signal as the processed signal data to the prosthesis controller.
5. The system according to claim 1, in, The implant device includes a protection circuit for protecting the implant device from surge voltages during an electrostatic discharge event while the implant device is implanted in a patient.
6. The system according to claim 5, in, The protection circuit includes at least one resistor and at least one diode.
7. The system according to claim 1, in, The multiple bipolar electrode pairs include a first group of bipolar electrode pairs and a second group of bipolar electrode pairs; wherein the first group of bipolar electrode pairs and the second group of bipolar electrode pairs are respectively connected to the implant device using a first multi-contact connector and a second multi-contact connector, each of which has a pair of contacts associated with a bipolar electrode pair; and wherein the implant device includes a head having a first port and a second port, and the first port and the second port are configured to receive the first multi-contact connector and the second multi-contact connector, respectively.
8. The system according to claim 7, in, The first port and the second port each include a BalSeal connector configured to seal the implant device 20 once the first multi-contact connector and the second multi-contact connector are inserted into the first port and the second port.
9. The system according to claim 1, in, The prosthetic device includes at least one pressure sensor, and the prosthetic controller is configured to: receive at least one pressure signal from the at least one pressure sensor and transmit the pressure signal to the implant device; and the processing circuit of the implant device is also configured to: receive the pressure signal, and generate at least one stimulation signal and transmit the at least one stimulation signal to at least one bipolar electrode pair among the multiple bipolar electrode pairs to stimulate the nerve of the object through at least one free tissue graft among the multiple free tissue grafts attached to the nerve of the object.
10. The system according to claim 9, in, The processing circuitry of the implant device is configured to alternate the receipt of the electrical signals with the generation and transmission of the at least one stimulation signal during consecutive time periods.
11. The system according to claim 10, in, The processing circuit is configured to generate commands to control the prosthetic device based on the received electrical signals, and to generate estimated commands to control the prosthetic device during a time period in which the at least one stimulation signal is generated and transmitted to at least one of the plurality of bipolar electrode pairs.
12. The system according to claim 9, in, The processing circuit is configured to estimate artifacts within the electrical signal generated by the at least one stimulation signal and to subtract the artifacts from the electrical signal.
13. A method, include: Receiving electrical signals from a plurality of free tissue grafts surgically attached to nerves of a subject using an implant device having processing circuitry and communication circuitry; wherein the electrical signals are received via a plurality of bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the plurality of bipolar electrode pairs being implanted within and in electrical communication with the plurality of free tissue grafts; the plurality of free tissue grafts being surgically attached to the subject such that the plurality of free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the plurality of free tissue grafts being autologous grafts of devascularized and denervated tissue harvested from the subject prior to being surgically attached to the subject; Processing the received electrical signal using the processing circuit; generating processed signal data using the processing circuit; and wirelessly transmitting the processed signal data to a prosthesis controller using the communication circuit; in: After the plurality of free tissue grafts are surgically attached to the nerve, portions of the nerve reinnervate the plurality of free tissue grafts; The electrical signals from the plurality of free tissue grafts have a voltage amplitude greater than or equal to about 150 microvolts; and The prosthesis controller is configured to control a prosthetic device based on the processed signal data wirelessly transmitted from the processing circuitry of the implanted device.
14. The method according to claim 13, further comprising: include: A bandpass filter is applied to the received electrical signal using the processing circuit, and the filtered electrical signal is sampled using the processing circuit.
15. The method according to claim 14, in, The band pass filter is a 100 Hz to 500 Hz band pass filter, and the sampling is performed at a sampling rate of 1 kHz.
16. The method according to claim 15, further comprising: include: The processing circuit is used to generate the processed signal data by calculating the average absolute value of the sampled electrical signal, and the communication circuit is used to wirelessly transmit the average absolute value of the sampled electrical signal as the processed signal data to the prosthesis controller.
17. The method according to claim 13, in, The implant device includes a protection circuit for protecting the implant device from surge voltages during an electrostatic discharge event while the implant device is implanted in a patient.
18. The method according to claim 17, in, The protection circuit includes at least one resistor and at least one diode.
19. The method according to claim 13, in, The multiple bipolar electrode pairs include a first group of bipolar electrode pairs and a second group of bipolar electrode pairs; wherein the first group of bipolar electrode pairs and the second group of bipolar electrode pairs are respectively connected to the implant device using a first multi-contact connector and a second multi-contact connector, each of which has a pair of contacts associated with a bipolar electrode pair; and wherein the implant device includes a head having a first port and a second port, and the first port and the second port are configured to receive the first multi-contact connector and the second multi-contact connector, respectively.
20. The method according to claim 19, in, The first port and the second port each include a Bal Seal connector configured to seal the implant device 20 once the first multi-contact connector and the second multi-contact connector are inserted into the first port and the second port.
21. The method according to claim 13, in, The prosthetic device includes at least one pressure sensor, the method further comprising: receiving, with the prosthesis controller, at least one pressure signal from the at least one pressure sensor; transmitting the pressure signal to the implant device using the prosthesis controller; receiving the pressure signal with the processing circuit of the implanted device; and At least one stimulation signal is generated using the processing circuit of the implant device and transmitted to at least one of the plurality of bipolar electrode pairs to stimulate the nerve of the subject through at least one of the plurality of free tissue grafts attached to the nerve of the subject.
22. The method according to claim 21, in, The processing circuitry of the implant device is configured to alternate the receipt of the electrical signals with the generation and transmission of the at least one stimulation signal during consecutive time periods.
23. The method according to claim 22, further comprising: include: generating, using the processing circuit of the implanted device, commands to control the prosthetic device based on the received electrical signals; Estimated commands for controlling the prosthetic device are generated, with the processing circuitry of the implanted device, during a period of time when the at least one stimulation signal is generated and transmitted to the at least one bipolar electrode pair of the plurality of bipolar electrode pairs.
24. The method according to claim 21, in, The processing circuit is configured to estimate artifacts within the electrical signal generated by the at least one stimulation signal and to subtract the artifacts from the electrical signal.
25. A system, include: a computing device having a processing circuit configured to receive electrical signals from a plurality of free tissue grafts surgically attached to nerves of a subject; wherein the electrical signals are received via a plurality of bipolar electrode pairs, each bipolar electrode pair having a positive electrode and a negative electrode, the plurality of bipolar electrode pairs being implanted within and in electrical communication with the plurality of free tissue grafts; the plurality of free tissue grafts being surgically attached to the subject such that the plurality of free tissue grafts are completely surrounded by and in direct contact with non-transplanted tissue of the subject; the plurality of free tissue grafts being autologous grafts of devascularized and denervated tissue harvested from the subject prior to being surgically attached to the subject; the processing circuit further configured to process the received electrical signals, generate processed signal data, and transmit the processed signal data to a prosthesis controller; in: After the plurality of free tissue grafts are surgically attached to the nerve, portions of the nerve reinnervate the plurality of free tissue grafts; said electrical signals from said plurality of free tissue grafts having a voltage amplitude greater than or equal to about 150 microvolts; the prosthesis controller being configured to control a prosthetic device based on the processed signal data transmitted from the processing circuitry of the computing device; The plurality of bipolar electrode pairs are connected to electrical leads extending to the exterior of the subject and to the computing device located exterior of the subject, the computing device being in communication with the prosthesis controller.
26. The system according to claim 25, in, The processing circuit is configured to apply a bandpass filter to the received electrical signal and to sample the filtered electrical signal.
27. The system according to claim 26, in, The bandpass filter is a 100 Hz to 500 Hz bandpass filter, and the processing circuit is configured to sample the filtered electrical signal at a sampling rate of 1 kHz.
28. The system according to claim 27, in, The processing circuit is further configured to generate the processed signal data by calculating an average absolute value of the sampled electrical signal, and wirelessly transmit the average absolute value of the sampled electrical signal as the processed signal data to the prosthesis controller.
